| 2004-01-12 11:09:00 |
App. 3B: Issue per AGM Resolutions & US Corp. Advisory Fees |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3caf026f7a8bd4d79b869b2e2ab76cf6 |
|
| 2004-01-13 09:10:00 |
Form 20-F Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/df90de675cf7d4fd6b0edc191afb8418 |
|
| 2004-01-16 13:30:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c918fb8dd1c43f755d866028c9dd88c |
Change of Director's Interest Notice
|
| 2004-01-16 13:31:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/32cd849d9139dda2e3b9a243c4b9cf9e |
Change of Director's Interest Notice
|
| 2004-01-16 13:32:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b9d4677f692cbb1191de9bac4a6e6ace |
Change of Director's Interest Notice
|
| 2004-01-30 16:27:00 |
Commitments Test Entity - Second Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d24066f85f003dc5863120f488813644 |
Commitments Test Entity - Second Quarter Report
|
| 2004-02-18 13:42:00 |
Aust Gov supports PBT2 drug with $1.35 million Start Grant |
1 |
https://app.sharelinktechnologies.com/announcement/asx/57d0c142403d0001c589abb926872910 |
|
| 2004-02-20 15:18:00 |
Appendix 3B - Corporate Advisory Fees |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fcb794a9646ce8bc1bdba86b124d76c9 |
|
| 2004-02-25 09:40:00 |
Dr Ashley Bush signs 10 year consultancy agreement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/953217c40dac5a64245698c65dfa24ca |
Company Administration - Other
|
| 2004-02-25 16:12:00 |
Half Yearly Report & Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0b708ae54070e5d566a7474df2256df9 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2004-03-17 17:05:00 |
Correction: Change of Registry address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8bde720ebe7bb71563f33d93f04e92c5 |
Details of Share Registry address
|
| 2004-03-25 09:08:00 |
Appoints leading US Sector Analyst to Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cd35dd10fefdec9b608f9a08c29d12df |
Company Administration - Other
|
| 2004-03-26 09:41:00 |
Added to Forbes Neurological Drug Watch List |
0 |
https://app.sharelinktechnologies.com/announcement/asx/35818b1962d884c9606fb00ee919ecb8 |
|
| 2004-04-01 17:20:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/275904d2f21cb9f098d139101292d6f2 |
Initial Director's Interest Notice
|
| 2004-04-07 15:06:00 |
Neuroscience validation of Prana Science |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2d2a4f1bb2d0733299a3e6a53b9e708d |
|
| 2004-04-08 16:20:00 |
Appendix 3B - Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/28acb1f6a4c8ce938900283c53643084 |
|
| 2004-04-13 09:29:00 |
WSJ article profiles challenges for Alt Alzheimer Research |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d58ad2917525c17eaeb3f5758fe6a8ca |
|
| 2004-04-15 17:15:00 |
Appendix 3B - Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/46c9294542604ed99576fb4f8fc3b98d |
|
| 2004-04-16 12:46:00 |
Alzheimer's drug shows cont. promise in ext. clinical trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b7233ab1c9f7d77622d633a61cbfd8da |
|
| 2004-04-16 17:56:00 |
Appendix 3B - Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/71285e9af9e50372f1735dbd34d02dbc |
|
| 2004-04-20 17:09:00 |
Appendix 3B - Exercise of options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2ca07de982ddca2b51b54caefb5168bb |
|
| 2004-04-22 10:07:00 |
Appendix 3B - Exercise of options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cbb1ba19c576e4418bfc728393210c5f |
|
| 2004-04-26 09:54:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3f20cf76c1a61056039ca53251be7074 |
|
| 2004-04-28 09:13:00 |
US Health Funds Invest USD 20 million in Prana Biotechnology |
1 |
https://app.sharelinktechnologies.com/announcement/asx/119d0d6da2d355f589f595f686d7aec6 |
|
| 2004-04-29 14:43:00 |
Commitments Test Entity - Third Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/40f0c1331cd754d8d83719e70b1d6dd9 |
Commitments Test Entity - Third Quarter Report
|
| 2004-05-03 09:59:00 |
Notice of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c76337e6b970783f002be09dff56f99d |
Notice of General Meeting
|
| 2004-05-03 14:35:00 |
New research suggests add role for PBT against Alzheimers |
0 |
https://app.sharelinktechnologies.com/announcement/asx/33493e64653e9fe19a2e9c433fda11d1 |
|
| 2004-05-10 14:35:00 |
Appendix 3B - Consultancy Services Agreement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e19cf250f184b0f21204d196374d4e15 |
|
| 2004-05-12 09:07:00 |
At the Rodman & Renshaw Techvest Global Healthcare Conf |
0 |
https://app.sharelinktechnologies.com/announcement/asx/83e9dda8a29e77166a63d19872a14502 |
|
| 2004-05-13 09:34:00 |
Founding scientist to present at Banc of America Healthcare |
0 |
https://app.sharelinktechnologies.com/announcement/asx/645e427413a34bfc305de6091af993da |
|
| 2004-05-20 09:54:00 |
Webcast available for Presentation at Banc of America Conf |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a3cf8d6d846ceb723a002e91a57b2480 |
|
| 2004-06-01 11:41:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6467da40817671178c07dd506a6e837a |
|
| 2004-06-02 13:18:00 |
US capital approved by Australian Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5c874345b01d5d8896f2dcc4c61547d4 |
|
| 2004-06-08 09:44:00 |
Form F-3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/32609955e3fa9b364be6f86540a35b4b |
|
| 2004-06-11 16:53:00 |
Appendix 3B - As per Resolution approving Placement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/674ae8902e4da158089e2c3c12142877 |
|
| 2004-06-16 15:55:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c51dc1fc69d71463923ea14cb2158e5d |
Becoming a substantial holder
|
| 2004-06-17 16:53:00 |
Prana's Scientists on Aust. ABC TV Science Program Catalyst |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2f7d251ebb6334f69bc54fd17d308c17 |
|
| 2004-06-21 10:10:00 |
ASIC Class Order |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fad59211c87ce7089516231fdb94a557 |
|
| 2004-06-23 10:03:00 |
Senior scientific consultant to take up FederationFellowship |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a95ccc72a04587d27e9bc5b0859a7a60 |
|
| 2004-07-02 17:15:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/327ee7a433320ed4f1146ea7183e2ccb |
Change in substantial holding
|
| 2004-07-20 09:41:00 |
Prana presents at 9th International Conference on Alzheimers |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5ac3d159644284c3346b7035648c8815 |
|
| 2004-07-27 11:05:00 |
Founding Scientist To Present at Banc of America Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/25fdd9e2e46cb878008ea4982369146f |
|
| 2004-07-30 12:55:00 |
Commitments Test Entity - Fourth Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/eaf8e7140352e79b934e26310dac1b69 |
Commitments Test Entity - Fourth Quarter Report
|
| 2004-08-06 11:48:00 |
Prana Biotechnology Appoints US Based CEO |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2769ce72459c4bc40a6f18c2bea2aa90 |
Company Administration - Other
|
| 2004-08-09 09:34:00 |
PBT added to Forbes Neurological Drug Watch List |
0 |
https://app.sharelinktechnologies.com/announcement/asx/35d9998be1f2f8ec5665768d7aef368a |
|
| 2004-08-09 10:02:00 |
Prana Settles Clioquinol Patent Litigation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ead1bb1f27d06557e435a802efc8a972 |
|
| 2004-08-09 11:47:00 |
Amendment - Prana Settles Clioquinol Patent Litigation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5fc899f3d5582ef502f86667b1d21599 |
|
| 2004-08-09 17:39:00 |
Appendix 3B - New Issue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8003f42d32f5ebfcc6f03101f2623a55 |
|
| 2004-08-25 11:40:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/60a2dcde734f4ce4fd63235cf4f3e0b4 |
|
| 2004-09-14 09:13:00 |
Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7d0064b45bfb403af0bbfdad57375459 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2004-09-16 17:40:00 |
Appendix 3B - In lieu of consulting services |
0 |
https://app.sharelinktechnologies.com/announcement/asx/36e9ef2f24d6221074aa63481de1b394 |
|
| 2004-09-29 09:44:00 |
Form 20F - Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01d1c200622ad12215eff53d232b40c3 |
|
| 2004-10-06 13:00:00 |
Dr Bush awarded 2004 Zenith Fellow Award for Research |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0a4f0d7ec42813159d1342117d12375f |
|
| 2004-10-12 09:42:00 |
Study reinforces positive Phase II results |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3505d1946d1ba26da8ddc73fe62628ef |
|
| 2004-10-14 09:22:00 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1a727afad81bd45857967f09dc5357cd |
Notice of Annual General Meeting
|
| 2004-10-15 10:40:00 |
Journal of Bio Chem Paper further validates Prana Science |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e7d511ae17241875a136e02924ee3d12 |
|
| 2004-10-18 11:57:00 |
Prana to Hold Analyst Day - 18/10/2004 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f5ac0bac9e56c07afd53c15bd25007a8 |
|
| 2004-10-18 12:00:00 |
Plans to initiate Phase II/III Alzheimers Disease Study |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5edfd21d2e6344c352a878a0a7efffc4 |
|
| 2004-10-20 09:25:00 |
To present at Rodman & Renshaw Annual Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1438f2b09850e01ecbcd73fcca925453 |
|
| 2004-10-29 16:37:00 |
Commitments Test Entity - First Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ef15c18b8e2248e2696972c92d892ebe |
Commitments Test Entity - First Quarter Report
|
| 2004-11-08 11:59:00 |
To present at CIBC World Markets 15th Annual Healthcare Conf |
0 |
https://app.sharelinktechnologies.com/announcement/asx/972e11e789679099fbe8302efa85127f |
|
| 2004-11-17 13:54:00 |
Results of AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/92760cd1442d40023a7a69a88d426376 |
|
| 2004-11-17 13:58:00 |
Results of AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/009dc4a6e3a630cadee730e74592d989 |
|
| 2004-12-08 10:48:00 |
Raises US$3.7 Million Through Exercise of 9.5 MillionOptions |
1 |
https://app.sharelinktechnologies.com/announcement/asx/16cc469d33e0b2b352dba42d6e13dce2 |
|
| 2004-12-08 17:23:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a7eae2cfe47b2b594a25241f443bd459 |
Change of Director's Interest Notice
|
| 2004-12-08 17:23:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3d14c434d9f9fa8a092d35aa012a1032 |
Change of Director's Interest Notice
|
| 2004-12-08 17:23:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b0d4e1bdca62e941d3349fcff7d67424 |
Change of Director's Interest Notice
|
| 2004-12-08 17:25:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6aee5bfad0b5badb3e3344235008f065 |
Change of Director's Interest Notice
|
| 2004-12-08 17:33:00 |
Appendix 3B - Exercise of Unlisted Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/80de590e173d54914ae9def8d18a2c6a |
|
| 2004-12-09 17:18:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/470e9853b73744b567353ba4516fec76 |
Change in substantial holding
|
| 2004-12-17 17:11:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d177ed1510a6afcaf62e7a292d2edbef |
Change of Director's Interest Notice
|
| 2004-12-17 17:13:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c7cd51af9a96c071d238794eb5d8c114 |
Change of Director's Interest Notice
|
| 2004-12-17 17:16:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1d888d8c93b318e154555c0cf546328a |
Change of Director's Interest Notice
|
| 2004-12-17 17:17:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/774efc0e6bd784ed0921b5e1d36b6f2a |
Change of Director's Interest Notice
|
| 2004-12-17 17:17:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cd3222c95ae8ade2250dd8df98302ae6 |
Change of Director's Interest Notice
|
| 2004-12-17 17:21:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8a62e91d60cda0942f2192a0912bfad6 |
|
| 2005-01-04 09:45:00 |
Prana Receives Clinical Trials Authorisation in UK |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bf656edf1f56d526fdb65c8132fa17d9 |
|
| 2005-01-31 12:40:00 |
Commitments Test Entity - Second Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/70d0d9956b5940c99653780cb4c95522 |
Commitments Test Entity - Second Quarter Report
|
| 2005-02-14 09:34:00 |
Maintains position on Forbes list |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c8336ad14b2205c33029844448894d67 |
|
| 2005-02-17 11:46:00 |
To Present at BIO CEO Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b43018d01238dedf67866e94aea4c6cb |
|
| 2005-02-21 17:17:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2818f69593966cdd60f70ae31b22816a |
|
| 2005-02-28 09:44:00 |
Half Yearly Report & Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1d65dbb1855df8419c0e2767a0b9b53b |
Half Year Directors' Statement
|
| 2005-03-15 09:13:00 |
Commences Phase 1 Clinical Trial of PBT2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/949dc3c870991cb41ac3be4fd8921903 |
|
| 2005-04-11 09:38:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d4ee6deed40c6f32f1aea4e699a8fd7f |
|
| 2005-04-11 13:34:00 |
Cancels Plans for Placque Clinical Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0cea427d783e0d310f775b70bfd3480d |
|
| 2005-04-28 09:25:00 |
Commitments Test Entity - Third Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f96add1a8fdefdb76df79814bdf6b688 |
Commitments Test Entity - Third Quarter Report
|
| 2005-05-04 16:33:00 |
To present at Rodman & Renshaw Techvest Healthcare Conf |
0 |
https://app.sharelinktechnologies.com/announcement/asx/da020527762dd4da6bcc57129f39d656 |
|
| 2005-05-13 09:19:00 |
To present at Banc of America Healthcare Conf 2005 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e85333f58c3700078b429e4ff5023a1c |
|
| 2005-05-24 15:43:00 |
To Present at Needham&Co 4th Annual Biotechnology Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/50f05a96e0bfc230b873eea36ff70ef5 |
|
| 2005-05-26 17:24:00 |
NASDAQ Filing - Form 20-F/A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/217fc7c188342b10861732e5f06088c7 |
|
| 2005-05-26 17:34:00 |
Form 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ea4ca53f600e4f7c9e840fcea1906bce |
|
| 2005-06-16 09:55:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/908d2a4a4e680ed3d4a8acb6593651e1 |
|
| 2005-06-16 12:40:00 |
Completes Review of Development Program |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3665e5244895e6b3266acdd814e4b6c7 |
|
| 2005-06-16 12:40:00 |
Management Change |
1 |
https://app.sharelinktechnologies.com/announcement/asx/877c3cb023dac79983be9d0835ca225a |
Director Appointment/Resignation
Company Administration - Other
|
| 2005-06-20 10:48:00 |
Co-Founding Scientists to Present at Alzeimer's Association |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1ce4592fcbf593453a095dc02670b6c9 |
|
| 2005-06-27 11:01:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bbe3e6c16dd974cf62703437397bd3ae |
Final Director's Interest Notice
|
| 2005-07-22 17:15:00 |
Securities to be Released from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/86d10148267251e7416f448839a0b0e1 |
|
| 2005-07-26 13:54:00 |
To Present at Bank of America 2005 Specialty Pharma Conf. |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8537f9d59bf3c8935f8af758b4540d2a |
|
| 2005-07-29 09:35:00 |
Prana Strengthens Board with Non-Executive Appointment |
0 |
https://app.sharelinktechnologies.com/announcement/asx/10ce8f659fc5285dcbc940c0b048a499 |
Director Appointment/Resignation
|
| 2005-07-29 16:50:00 |
Commitments Test Entity - Fourth Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/900c1452e461bc906e17570180ffb92a |
Commitments Test Entity - Fourth Quarter Report
|
| 2005-08-02 17:46:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/907aac17a9d596d8791ccae1c4553601 |
Initial Director's Interest Notice
|
| 2005-08-09 17:20:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8d56974649c85830683d38dccbc2c09b |
|
| 2005-08-10 17:22:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a1be3676d3eaec4ece6c52254a065fec |
|
| 2005-08-23 17:24:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e967afedf42f8ba328f76f769513792b |
Ceasing to be a substantial holder
|
| 2005-09-09 17:16:00 |
Appendix 4E - Preliminary Financial Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9efb771a866b0571f9db973a3fe99d12 |
|
| 2005-09-30 15:59:00 |
Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cc4ccab8799fc250337d70cf3669a6d1 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2005-10-03 11:41:00 |
Form 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/40ae8eee941744fb4147920e223a8f4f |
|
| 2005-10-24 17:09:00 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ab994e0f14e11f507a884ef61979a8e2 |
Notice of Annual General Meeting
|
| 2005-10-28 16:49:00 |
Commitments Test Entity - First Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1dc47afbbdedb566818aa163b835ec16 |
Commitments Test Entity - First Quarter Report
|
| 2005-11-03 14:35:00 |
To present at Rodman & Renshaw Techvest Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/db0b16b9a517cdad5818f3bec29e9677 |
|
| 2005-11-07 09:32:00 |
PBT2 demonstrates safety in Phase 1 Human Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8ace96bec9be6db1245b2d514c8b7454 |
|
| 2005-11-14 16:11:00 |
Prof. Bush to present study findings at Neuroscience 2005 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3640fc92e785ef0946db9a63c57fc5c9 |
|
| 2005-11-30 12:58:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9b373682a8e8a3fddc82e62937707c86 |
|
| 2005-12-23 15:26:00 |
Form 20 F |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5f809bec0e8315d0defcd11e1c8dafaa |
|
| 2006-01-30 16:52:00 |
Commitments Test Entity - Second Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f056cb9443c4fa73535228340d6e9fc2 |
Commitments Test Entity - Second Quarter Report
|
| 2006-02-01 10:23:00 |
Aging Cell Paper Further Validates Prana Science |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3af15fda5ec80fef35d64469657686ab |
|
| 2006-02-02 17:29:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c5fc72c6d7c0cc6c61cf6ce20304f597 |
|
| 2006-02-07 09:25:00 |
PBT2 successfully completes initial Phase 1 clinical trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/92724e9df0645fe4d773630b1c2ac5ac |
|
| 2006-02-07 09:54:00 |
Amended Copy - PBT2 Completes Phase 1 Clinical Trial Program |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f7fe93b26d9bafa0780fa6018837ef3f |
|
| 2006-03-03 11:07:00 |
ZSP: March Quarterly Rebalance to the S&P/ASX Indices |
0 |
https://app.sharelinktechnologies.com/announcement/asx/06a88786d696f780fb923bfc079a4123 |
Standard and Poor's Announcement
|
| 2006-03-07 09:08:00 |
Half Yearly Report & Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c434c7244e1a1b075afe152e48ad11ea |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2006-04-03 10:26:00 |
Form 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/26b08443cc86f35c93ff76f9187c5c66 |
|
| 2006-04-10 17:36:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c1792b95b934ecf33458c0a41644a2f8 |
Change of Director's Interest Notice
|
| 2006-04-10 17:36:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2fdc92dc88cfd87e6185fe575d3fb69a |
Change of Director's Interest Notice
|
| 2006-04-28 10:54:00 |
Commitments Test Entity - Third Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/89c9a686063ce359b2237c6d10e0d7a8 |
Commitments Test Entity - Third Quarter Report
|
| 2006-05-05 09:20:00 |
Independent Report Received on PBT2 Phase 1 Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/665d1b33645f721c8f5c9d492a9af3d4 |
|
| 2006-05-11 16:15:00 |
PBT2-Phase IIa Clinical Trial-Alzheimer's Disease Patients |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1919bcd7217f40d0c9bc48f006600b0d |
|
| 2006-05-12 09:59:00 |
Confirmation of Conference Call Details |
0 |
https://app.sharelinktechnologies.com/announcement/asx/471aa60ab38ccfbc48d9661e2e585cee |
|
| 2006-06-30 17:18:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/855eb15d3b5b79dd6e793ea38f3ebf53 |
|
| 2006-07-18 09:57:00 |
To present at Intl Conference on Alzheimers Disease |
0 |
https://app.sharelinktechnologies.com/announcement/asx/19d208ab600c98d5b52bf7072b23865d |
|
| 2006-07-20 09:53:00 |
PBT2 demonstrates rapid & potent effects |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0b99b351858e5ff8676320123d4a02a6 |
|
| 2006-07-24 13:38:00 |
Additional Comment on PBT2 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3a3aa37308f8dc4e17997556c13edef1 |
|
| 2006-07-27 09:49:00 |
Co-Founding Scientist receives Lifetime Achievement Award |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3413d0c51b98fb48105c0aef6043b6ad |
|
| 2006-07-31 14:59:00 |
Commitments Test Entity - Fourth Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ee1c8c3e2b2e59c457eb2b92e2d671e2 |
Commitments Test Entity - Fourth Quarter Report
|
| 2006-08-07 10:03:00 |
To Present at Banc of America 2006 Specialty Pharma Conf. |
0 |
https://app.sharelinktechnologies.com/announcement/asx/69c6e02963a99ff0e017f5e9f3c60a00 |
Company Administration - Other
|
| 2006-08-31 09:29:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c84f1652ada0db806d35ff193777326 |
|
| 2006-09-07 16:56:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9e789b65d77e6cc2196426db04485a91 |
|
| 2006-09-28 16:29:00 |
Co-founding Scientist Selected as one of The Harvard 100 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5affb78dc31b6a8cc8db4c085bc96709 |
|
| 2006-09-29 17:17:00 |
Annual Report 2006 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/af0506c178a30091df67637d1ae12bff |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2006-10-02 10:15:00 |
Form 20-F |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3dbef32919c5a631677aadc14a8aacbf |
|
| 2006-10-05 10:02:00 |
Regulatory Approval to Start PBT2 Phase 11a Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/494132b8db4103ede9b1bda95c5afdba |
|
| 2006-10-13 16:36:00 |
Auditors Provide Going Concern Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c13be0d2a54bcbab4f85a4376569658a |
Company Administration - Other
|
| 2006-10-13 16:54:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ba9eed84ca0bb4d1a28ffe4790d2fcdc |
|
| 2006-10-16 09:30:00 |
Co-founding Scientist to Receive Intnl Prize for Excellence |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b03cd6a050d55acb3648a5e259131729 |
|
| 2006-10-16 17:11:00 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ce7a067c6fe151007d74f272f54935d3 |
Notice of Annual General Meeting
|
| 2006-10-30 17:12:00 |
Commitments Test Entity - First Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f361d85919eb6dbb4f8104494b6d1e84 |
Commitments Test Entity - First Quarter Report
|
| 2006-11-01 09:33:00 |
To present at Rodman & Renshaw 8th Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/87ca25a6974477602fafa30684d2ce68 |
|
| 2006-11-17 11:46:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d6ec04552327dbaff773bcec05c7aa96 |
|
| 2006-11-21 10:06:00 |
Prana raises A$7.8M to Fund Phase IIa Clinical Trial of PBT2 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6f603fe2e1ecc93da58bbf837fe89ebd |
|
| 2006-11-23 17:23:00 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2a80bedf13637e8c2451ad319ecaf24f |
Notice of Annual General Meeting
|
| 2006-11-29 16:23:00 |
Section 708A(5) Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/05feb6ff69c95934ac12c59b2a8cf246 |
|
| 2006-11-29 16:26:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1fe2334318cfd3831467b7b2038abb15 |
|
| 2006-11-29 16:31:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c5dbf17165b903c1914d29f2fcd78483 |
Change in substantial holding
|
| 2006-11-30 13:28:00 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/83a359cfa059d8bac26c89c421634223 |
|
| 2006-12-04 12:06:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fb19806030ab7f0983bf9e8ce4232bea |
|
| 2006-12-06 09:41:00 |
Co-Founding Scientist Apptd Executive Director of MHRI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7f3f1c539ab1d99a001a17b298c6e382 |
Company Administration - Other
|
| 2006-12-15 16:57:00 |
Becoming a substantial holder from AMP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d96ef3a1ef6b01720b953f38518a5633 |
Becoming a substantial holder
|
| 2006-12-18 10:27:00 |
Change of Director's Interest Notice x 5 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b035f7049b251dcb8563166f37bb182e |
Change of Director's Interest Notice
|
| 2006-12-19 09:41:00 |
Co-founding Scientist receives Grand Hamdan Internat. Award |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9c55c90b5926c5ae0703e0d34cfad1fd |
|
| 2006-12-20 09:57:00 |
Dosing Commenced in Phase 11a PBT2 Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c87d1a35a0d30815e4843e57abe8b15b |
|
| 2006-12-28 09:56:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7ea2fc673e9d69017a8127a03fb4172d |
|
| 2006-12-28 09:59:00 |
Appendix 3B & Section 708A (5) Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/228b6b9abf09fdd048cc6e6d8e6ea280 |
|
| 2007-01-31 16:50:00 |
Commitments Test Entity - Second Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c7957c2f5759ef30433ce6a9def43604 |
Commitments Test Entity - Second Quarter Report
|
| 2007-02-28 14:48:00 |
Half Yearly Report & Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d62cae7cbb3982fc4ee7a3a32d1b6318 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2007-03-22 14:06:00 |
Prof Cummings appoint Chair of R & D Advisory Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e80918c0c18c8da1c8a24645aabe223 |
Company Administration - Other
|
| 2007-03-29 09:57:00 |
Form 6K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3740e5b53ccfdb7ee447cd056adb4c29 |
|
| 2007-04-16 17:41:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/87a8c2ad5e69a94ca3153100d9272354 |
|
| 2007-04-23 11:30:00 |
Two US-based Pharmaceutical Executives Appointed |
0 |
https://app.sharelinktechnologies.com/announcement/asx/014478b85d90dc946355aea7eec17070 |
Company Administration - Other
|
| 2007-04-27 16:48:00 |
Commitments Test Entity - Third Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/455187f13a25a5b41467281db361eafe |
Commitments Test Entity - Third Quarter Report
|
| 2007-05-03 15:12:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e5840b33396fa97b6787416c6716303c |
|
| 2007-05-08 14:15:00 |
Prana to present at Global Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0ccc4f0fbefc30f59f6e298fa2391bd4 |
Company Administration - Other
|
| 2007-05-28 09:34:00 |
To present at Bank of America Health Care Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a7c8946cad1d88925cff465d43bc4a56 |
|
| 2007-05-31 09:29:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/246f5aca4479f964c8924c1108c9bd8e |
|
| 2007-06-07 09:18:00 |
Presents new key findings on PBT2 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/16c1212267a1d388c7ba76b6baa8a952 |
|
| 2007-06-12 16:59:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/00fcf531a47e7a720f43160f54e9b82b |
|
| 2007-06-19 09:53:00 |
Form 20-F/A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/16a504fd92d1c29352eebd62e58aaafb |
|
| 2007-06-19 16:48:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e8a8448fd0638c6e74095c5aa1540dc6 |
|
| 2007-07-02 13:47:00 |
Director Retirement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3c8aaa5ebf36ea06c850b706ed54f3f8 |
Director Appointment/Resignation
|
| 2007-07-04 11:31:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d594214f8c937c310447030e0014af4d |
Final Director's Interest Notice
|
| 2007-07-30 16:38:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ebe2b8cb7f5ba8a23f4ffa2772a78971 |
Commitments Test Entity - Fourth Quarter Report
|
| 2007-08-06 09:41:00 |
Update on Phase 11a Trial of PBT2 in Alzheimer`s Patients |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e455ded64bdf9522fa6ef768379587ad |
|
| 2007-08-14 10:46:00 |
Implications of Metal Ion-Binding Studies |
1 |
https://app.sharelinktechnologies.com/announcement/asx/45894c6a282b23325a8c84aa1b773dbf |
|
| 2007-08-16 09:20:00 |
Founding Director of Prana Receives the Victoria Prize |
0 |
https://app.sharelinktechnologies.com/announcement/asx/79890ac64a9ae8af9ab10291e477e42a |
|
| 2007-08-20 17:31:00 |
Letter to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a8f544635547537298adcc26812f594e |
|
| 2007-08-31 09:10:00 |
Change in substantial holding - AMP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/09b3e2eeea409a300810088b3c845ff0 |
Change in substantial holding
|
| 2007-08-31 16:40:00 |
Appendix 4E |
1 |
https://app.sharelinktechnologies.com/announcement/asx/37d7a2f976dd3a1db51539f0ca7e9d00 |
Full Year Directors' Report
|
| 2007-09-12 10:17:00 |
Prana to raise A$7m from Institutional and Prof. Investors |
1 |
https://app.sharelinktechnologies.com/announcement/asx/68db15d9744ca51770b45d819b05dd69 |
|
| 2007-09-12 10:20:00 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b993b2e92291594e9d5484ed1fee9bcb |
Notice of General Meeting
|
| 2007-09-21 09:34:00 |
Prof. RudolphTanzi to participate in Expert Panel Discussion |
0 |
https://app.sharelinktechnologies.com/announcement/asx/775cd054483fbf70bcaea9b0a86d6c73 |
|
| 2007-09-24 13:56:00 |
Prana Completes Enrollment in Phase 11a Trial of PBT2 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/33d411fa24ef6dc4096f567357535c04 |
|
| 2007-09-27 17:18:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/895c701519f86e65474ba093ac069fea |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2007-10-01 12:04:00 |
Form 20-F |
0 |
https://app.sharelinktechnologies.com/announcement/asx/be1cef826eb99071fd15086e520107ce |
|
| 2007-10-01 12:41:00 |
Prana Announces Filing of Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fb41e2d78c9081fb4afd3691d6a697b6 |
|
| 2007-10-15 15:51:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/82c9a46bd7fab896657eff9ec60336ab |
|
| 2007-10-17 17:17:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b2f362fe86fc7a026035a1eadceda9fd |
|
| 2007-10-17 17:34:00 |
Notice Under Section 708A(5) of the Corporations Act |
0 |
https://app.sharelinktechnologies.com/announcement/asx/280e40ac61db72f8eb32a518ac37ad69 |
|
| 2007-10-19 17:03:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/25e9e6556da6007a2bcc096f2be7b78d |
Change in substantial holding
|
| 2007-10-19 17:10:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ecb00708d6b28f9d222d281049023b12 |
Change in substantial holding
|
| 2007-10-24 17:09:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cbcd90d2dec7075ef7226962219a305d |
|
| 2007-10-29 14:12:00 |
Prana to Present at Rodman and Renshaw Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/912be974c22961f9f81fc03382f023c8 |
|
| 2007-10-30 17:56:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3f246dfab8fa3ca88d28b16e35ebd155 |
|
| 2007-10-31 16:23:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/028fa44885d442d103e2048a4d7725f7 |
Commitments Test Entity - First Quarter Report
|
| 2007-11-01 14:14:00 |
Prana Closes Approximately A$8 million Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e5413e8258c697ecc76f7e6d386d75c9 |
|
| 2007-11-08 08:37:00 |
Ceasing to be a substantial holder - AMP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b897afe3c7bb441cdd8f2dede691babb |
Ceasing to be a substantial holder
|
| 2007-11-08 17:41:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/592a440824ff8ce47d72ebeb6620456c |
Notice of Annual General Meeting
|
| 2007-11-28 17:09:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/29796284cf2701022ec6e5673e45f24e |
|
| 2007-11-29 10:01:00 |
Positive Report From Independent Data Safety MonitoringBoard |
1 |
https://app.sharelinktechnologies.com/announcement/asx/664f482b53507337ade574c818498959 |
|
| 2007-12-03 10:03:00 |
Letter to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/18cef5052564ee8896fce7e500321779 |
|
| 2007-12-06 09:16:00 |
Prana to Co-Host Expert Panel Discussion |
1 |
https://app.sharelinktechnologies.com/announcement/asx/76e2295ef45541461fb9d3b0abd072b1 |
|
| 2007-12-12 10:00:00 |
Co-Founding Scientist to present at Credit Suisse Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8dc909d1ed4664bf20f8796dc14ff226 |
|
| 2007-12-18 10:52:00 |
Final Patient Dosing in Phase 11a trial of PBT2 Completed |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ace6d6ab1d72fa1ac88be0877b348fcc |
|
| 2007-12-20 12:32:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/103a9684fdc4175e528b34363c9b9f07 |
|
| 2007-12-20 12:36:00 |
Constitution |
0 |
https://app.sharelinktechnologies.com/announcement/asx/78d8f9bf56f47a4c64628254ae5f1bd0 |
|
| 2007-12-20 13:58:00 |
Prana provides update on Research and Development Program |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3e59a24e0b9dd3247d01318596a25ec5 |
|
| 2007-12-24 09:20:00 |
Form F-6 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/84d54fd3a685d491d46c405badce5c5e |
|
| 2007-12-24 13:24:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/29e897051eccd75da7bc2a7a5f292b77 |
|
| 2008-01-02 09:53:00 |
Prana Announces Completion of Phase IIa Trial of PBT2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e22a40de2520db646afe5ef21f4ee249 |
|
| 2008-01-18 14:08:00 |
Prana announces Publication in Neurobiology of Aging Journal |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3f088a747eb45bc63893eae4ffaf7ce9 |
|
| 2008-01-31 12:01:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/05f20a50ea527bcf36b804612e8e846e |
Commitments Test Entity - Second Quarter Report
|
| 2008-02-15 16:34:00 |
Appendix 4D |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8b37efabc6f81c0f2329359341ed8861 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2008-02-18 09:09:00 |
Form 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c15d8fa1ad5828205b4634e95449dcda |
|
| 2008-02-25 09:12:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d0c0d27f668d98e9e010a1693e9779d1 |
|
| 2008-02-26 10:05:00 |
Success in Phase IIa Clinical Trial of PBT2 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2b6c51de3248aecdb4427918f4172071 |
|
| 2008-02-27 09:15:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c73c2e107079a1d22bd85fac3cf15c04 |
|
| 2008-02-27 09:44:00 |
Section 708A notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9de93af39beb2766700049d65e849ee6 |
|
| 2008-03-03 09:19:00 |
Post-Effective Amendment No.1 to Form F-3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5d3448b0f3eb8c8af5774c085788de90 |
|
| 2008-03-04 16:08:00 |
Prana responds to Press comments |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8c72e77c8e28a02da5729446b571f43a |
|
| 2008-03-12 10:27:00 |
Prospectus |
0 |
https://app.sharelinktechnologies.com/announcement/asx/83b8205b4aa166fca6b9242c69e6fb5e |
Structured Products Disclosure Document
|
| 2008-03-13 09:30:00 |
Prana to Present at Cowen and Company Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/23e39a48685748864af5df344df16c87 |
Chairman's Address - Other
|
| 2008-03-13 16:31:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5ff055c38f19b4ee7ff654409b6198e8 |
Becoming a substantial holder
|
| 2008-03-14 12:23:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d7b19561ce4835885cad54c02108517a |
|
| 2008-03-14 12:30:00 |
Appendix 3Ys - GK, GM, PM, BM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/73612d536f5d285e770746926ff856fc |
Change of Director's Interest Notice
|
| 2008-03-14 12:35:00 |
Clarification of ADR Warrants - ADR Conversion Incentive |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6835b582de3f0b07d5677347957df8af |
Structured Products - Other
|
| 2008-03-14 12:48:00 |
Prana to be Featured in Alzheimer`s Disease Conference Call |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a9a0c05d646e18295d0a81a08a2d72c9 |
|
| 2008-03-14 14:07:00 |
Prana Announces Updated Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5322ca2604cdbdb340ff55b71ecbf2fc |
|
| 2008-03-18 09:20:00 |
Increase in Percent of Major Shareholder Ownership |
0 |
https://app.sharelinktechnologies.com/announcement/asx/737c9a0fcce49fced9a9515d53708d0b |
Security holder details - Other
|
| 2008-03-20 16:00:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/62ee962bd7b3952cef7f8b06f11731ef |
|
| 2008-03-31 09:22:00 |
Form 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee101e6101fe7174df615ec62bfef0d5 |
|
| 2008-04-02 17:22:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ae8b89b33ae7df3b138e2067ec4c0d07 |
|
| 2008-04-09 17:15:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5105e6a03c04d90f430c516a827a9d4b |
|
| 2008-04-24 16:48:00 |
Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bf11594418e100961918a99022d3e9cd |
Commitments Test Entity - Third Quarter Report
|
| 2008-05-06 11:50:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0991f501938e76470cf8766672c4c907 |
|
| 2008-05-06 12:07:00 |
Trading Halt Request |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6499f0c327c8acc4e84fb33c0c59664e |
|
| 2008-05-06 14:52:00 |
Novel drug candidates discovered for Parkinsons Disease use |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8f34fb9a21060116c2d9abf47eceb885 |
|
| 2008-05-13 09:43:00 |
PNAS Publication Describes New Class of Anti-Amyloid Drugs |
1 |
https://app.sharelinktechnologies.com/announcement/asx/56d19bcbe93bfa4d4ce6041397872712 |
|
| 2008-05-15 17:20:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dbf4e610ff33fc10f4ad269cad658350 |
|
| 2008-05-21 09:59:00 |
$7 million Placement to Fund Research Programs |
1 |
https://app.sharelinktechnologies.com/announcement/asx/974572f11443943d4df0f2aa19a077a5 |
|
| 2008-05-26 10:43:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7d79a30c85607e62b30d0e2d95372f99 |
Change in substantial holding
|
| 2008-05-27 17:44:00 |
Appendix 3B and Section 708A Notice - New issue of shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c6ff06a83b167f4637b9a6e89dfb9cc |
|
| 2008-05-28 17:04:00 |
Notice of change of interests of substantial holder - Jagen |
0 |
https://app.sharelinktechnologies.com/announcement/asx/49b1e7ef8678f0fb8cf752a6869758fe |
Change in substantial holding
|
| 2008-05-28 17:06:00 |
Notice of change of interests of substantial holder -Baywick |
0 |
https://app.sharelinktechnologies.com/announcement/asx/06fe1f0a7d483afa451926c3c57a7c27 |
Change in substantial holding
|
| 2008-06-02 17:58:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/17716cdebb6d7d5bd70e5478456cd449 |
|
| 2008-06-12 17:22:00 |
Appendix 3B and Section 708A notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7ba4c89891f1c79ae94791287274f086 |
|
| 2008-06-25 17:13:00 |
Appendix 3B and Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9b8284bf9272520586a4a420e02531e9 |
|
| 2008-07-08 10:02:00 |
Co-founding Scientist Addressed US Senate Committee on Aging |
0 |
https://app.sharelinktechnologies.com/announcement/asx/acc32e125ada79fa5ceda16373cb28ea |
|
| 2008-07-10 10:15:00 |
Neuron to Publish Pranas PBT2 Preclinical Research |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9cef33b1662b6bddc8af0dfea0ba5ad9 |
|
| 2008-07-17 09:39:00 |
Prana Selected for Hot Topics and Press Briefing at ICAD |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e315d0562cbfb5bb9548b7b23838a436 |
|
| 2008-07-23 09:29:00 |
Prana Announces Conference Call Following ICAD Presentations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/be0ae0ec5d99b6929dc8d1a0249bad3b |
|
| 2008-07-23 17:15:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/57a290613f8dac7366245d6e256bf760 |
|
| 2008-07-30 09:21:00 |
The Lancet Neurology Publishes Clinical Results of PBT2 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4621b0324a8b03a2c58d25667ec1847a |
|
| 2008-07-31 17:03:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/22c0889aad00a772d01cd2c68e22428c |
|
| 2008-07-31 17:24:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3e254e22de09de5e343aa201e0d7d2dc |
Commitments Test Entity - Fourth Quarter Report
|
| 2008-08-27 17:04:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6870397083980e3b700a26375ff6d993 |
|
| 2008-08-28 18:14:00 |
Appendix 4E Preliminary Financial Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/98a340fac10e252838c0d1ca2157b57f |
|
| 2008-09-03 17:44:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d3ca11d2bb726cfb04c113ea00633a10 |
|
| 2008-09-25 16:55:00 |
Annual Report 2008 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/020777deae618879dd096c4d290aeca3 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2008-09-26 09:18:00 |
Form 20-F |
0 |
https://app.sharelinktechnologies.com/announcement/asx/57e936054e5932caf6f99a0f3bed114c |
|
| 2008-09-26 09:25:00 |
Form S-8 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b1f5f402866704c99298ad9b66dedff5 |
|
| 2008-09-29 09:40:00 |
Prana Announces Filing Of Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fa924b59d1c39eba35ff751396c434bb |
|
| 2008-10-15 17:52:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/746887ab45b2f603cd5c83cba314d723 |
|
| 2008-10-17 16:42:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f46321234cb766ff1c136aeeb7f0d471 |
|
| 2008-10-20 12:18:00 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bb89f8e518c15d74972714d492d53fd7 |
Notice of Annual General Meeting
|
| 2008-10-30 09:04:00 |
PranaTo Present at Rodman and Renshaw 10th Annual Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a4eab23f9289b565607839b3dc5ad275 |
|
| 2008-10-30 17:24:00 |
Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1e5f5dec70cc5e3092dba2c752cd67e3 |
Commitments Test Entity - First Quarter Report
|
| 2008-11-17 16:37:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7c2d05dbadf105d4f055e584e6ac1440 |
|
| 2008-11-18 11:51:00 |
Prana`s Compound Featured in Annals of Neurology |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48ba85c9cf0f3016376f2a23177760f3 |
|
| 2008-11-28 10:40:00 |
Prana Provides Update on Research and Development Programs |
1 |
https://app.sharelinktechnologies.com/announcement/asx/25782106fe627ba8827ec9b5e28b1623 |
|
| 2008-11-28 12:17:00 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3c5cde4eefcc049a7c821675dfd11510 |
|
| 2008-12-03 16:43:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e42cb79b51312f8b65c097ff215cf8fb |
|
| 2008-12-04 17:07:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d23ebf20dbe88f79ac1d8e6b34ce1729 |
|
| 2009-01-05 14:00:00 |
Co-founding Scientist to Present at Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/637a0f1b3c2f77ed16c8f0796f05c9a1 |
Chairman's Address - Other
|
| 2009-01-30 12:02:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/19f0d19a199e7b93a9725304c09c51a4 |
Commitments Test Entity - Second Quarter Report
|
| 2009-02-18 17:10:00 |
Appendix 4D |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9c56e2e5b4a0638295d5ce4a525fbfa5 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2009-02-23 09:49:00 |
Form 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5a971e9af839e63e514b9a8054664a07 |
|
| 2009-03-03 17:35:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c88ec76e4a64d0140fd834d4769d9ae |
|
| 2009-03-06 09:14:00 |
SandP Announces March SP/ASX Index Rebalance |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bbddb5a40f6d7979bd40cf7c6fce03b1 |
Standard and Poor's Announcement
|
| 2009-03-11 09:31:00 |
Prana`s PBT2 Prevents Synaptic Loss in Alzheimer`s Disease |
1 |
https://app.sharelinktechnologies.com/announcement/asx/00d79c48cddde11238d5ca458ab9b349 |
|
| 2009-04-02 09:42:00 |
Study Corroborates Prana`s AD Strategy |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3bca95271e7955ee8728743750450ddb |
|
| 2009-04-30 10:30:00 |
Appendix 4C - Quarterly Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1181017d71072fc4bcd6cc068e18b8b3 |
Commitments Test Entity - Third Quarter Report
|
| 2009-06-16 17:44:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/341c4309e94cfd7baaa708cb5755ef89 |
|
| 2009-07-10 14:08:00 |
Prana to Provide Update on PBT2 Efficacy Data |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5aa4c4cb7b5890daa3357b781795dcdd |
|
| 2009-07-15 17:24:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/19d350c511826d030f6515d3ee554bf6 |
|
| 2009-07-16 09:05:00 |
Prana`s Head of Research Presents New Efficacy Data |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4cf5d9b73a6d5db77b8b483e14fac88b |
|
| 2009-07-30 17:07:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9843491b037d88f33854bff90587f476 |
Commitments Test Entity - Fourth Quarter Report
|
| 2009-08-04 11:41:00 |
Change of Director`s Interest Notices |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f3eea4a436e01cc5388726cd8650aaf6 |
Change of Director's Interest Notice
|
| 2009-08-05 09:27:00 |
Prana is Granted Key Patent by European Patent Office |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e384d22a989570ef9762a024eeeef873 |
|
| 2009-08-06 10:18:00 |
Post Effective Amendment to Form F-3 registration statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/11e36f63f1619be5ded98fa1f5e25db5 |
Security holder details - Other
|
| 2009-08-12 14:33:00 |
Prana Allowed Key Patent for PBT2 in the United States |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5a9d9ab07d03d117da574ce969d1e3d9 |
|
| 2009-08-26 15:42:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c303d9dae09e2326cdd1bbadce72c08a |
Full Year Directors' Report
|
| 2009-09-02 15:43:00 |
Prana to Present at Rodman and Renshaw Global Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fe17a7c35f9af64516ea55bd066d1855 |
|
| 2009-09-02 16:49:00 |
Appendix 3B and Section 708(A) Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8d3bfe2b8e5852355a320a54a1a992a0 |
|
| 2009-09-09 09:12:00 |
Prana Secures $6 million Additional Financing |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7cd2f1998b3a2ff28b0fd182ab0d78c6 |
|
| 2009-09-11 13:04:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a485b76ed9124683f761f7e62d5e91d3 |
|
| 2009-09-15 15:28:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/53ceaeb5af97e85df197c811af17de0a |
Becoming a substantial holder
|
| 2009-09-16 17:51:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4a482f5d398b1166bdfd42f076b882df |
Change in substantial holding
|
| 2009-09-18 08:28:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b1ddab6355fb4371301bd156ae9f79f2 |
Becoming a substantial holder
|
| 2009-09-23 16:45:00 |
Annual Report 2009 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dfbabf8dae8f595e9cef177b1d12303c |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2009-09-24 14:44:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/67c3e9544250af982ab79d4cc4eb437c |
Change in substantial holding
|
| 2009-09-25 09:20:00 |
Form 20-F |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7bb3402f1aefb4e06b0a3f7ea270d2db |
|
| 2009-09-28 10:21:00 |
Form F-3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6b01502074aa8f735f519419c51edc50 |
|
| 2009-10-06 11:45:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b6318deb713bb11959359cb983babf2d |
Change in substantial holding
|
| 2009-10-08 16:39:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2c0e376d0b6fa1ad11b3997a63f494ca |
|
| 2009-10-09 12:56:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8bcd318b5e67f24a989e14d636706533 |
Change in substantial holding
|
| 2009-10-23 17:16:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1e4549c7cbec47b6d756c77d229ccdd7 |
Notice of Annual General Meeting
|
| 2009-10-28 17:46:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1351d985d3db3a50c9ff44624b3ad83d |
Commitments Test Entity - First Quarter Report
|
| 2009-11-06 08:29:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6721805f43ac754791cdfe583e048c05 |
Becoming a substantial holder
|
| 2009-11-06 19:19:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b5ad29a795233e6dd828073ab3b12a19 |
Becoming a substantial holder
|
| 2009-11-10 12:29:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ca1967e9c5b7c35c29393f473b7be2a7 |
Change in substantial holding
|
| 2009-11-12 10:13:00 |
Prana to Present at Windhover`s Therapeutic Area Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6b40ed5c56623edbfea3c40bf02d3310 |
|
| 2009-11-27 11:22:00 |
Results of 2009 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a5b6bf60b7f5732864eb97f0a2b922ea |
|
| 2009-11-27 17:34:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4ba71e290024ee12a4a56a7dc3699bd1 |
|
| 2009-12-01 17:45:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2ca7e1612a2c24eeac430e65509fb27e |
Change in substantial holding
|
| 2010-01-07 09:13:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/77ca6ec692c89ae437d301bfa0dc3ecb |
Change in substantial holding
|
| 2010-01-14 14:25:00 |
Appointment of Independent Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0e200b7fb9db73fef408364fb6b4266b |
Director Appointment/Resignation
|
| 2010-01-14 14:43:00 |
Appendix 3X |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ae4627b04d0418a3acf19a180cf3c714 |
Initial Director's Interest Notice
|
| 2010-01-29 16:53:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5b3146730f0711d255f9930be9efa787 |
Commitments Test Entity - Second Quarter Report
|
| 2010-02-25 16:44:00 |
Appendix 4D for the Half Year Ended 31 December 2009 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bb1a97c0dc1d0410e1952d23b90453cc |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2010-02-26 09:49:00 |
Form 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/28432b2e7674ca72620198b283ced48f |
|
| 2010-03-01 14:41:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8753f84728495a85a565d5cd12c58b91 |
Ceasing to be a substantial holder
|
| 2010-03-02 17:22:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5cbb14d2e25c12672add6b8d1dfd3b9a |
|
| 2010-03-05 09:32:00 |
SandP Announces March SP/ASX Index Rebalance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7d0576e932d4a6868fa93e19d30eb222 |
Standard and Poor's Announcement
|
| 2010-03-05 09:46:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0006a0fd25ad7b6561574aad3a072c2d |
Change in substantial holding
|
| 2010-04-19 10:06:00 |
New Analysis of Clinical Trial published in Journal of AD |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cfbc37828d35fb6adc6673e7079eaa08 |
|
| 2010-04-20 14:00:00 |
Prana to commence Phase 11b trial on PBT2 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/527e2a0d621eef54606c5f229124b013 |
|
| 2010-04-23 10:57:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ff2603c6806bc9a1a6ac7d01b722a9d6 |
Ceasing to be a substantial holder
|
| 2010-04-29 14:14:00 |
Prana Provides Analysis of PBT2 Therapeutic Strategy for AD |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0c0788a2c59ccd59f433f21c55eba11a |
|
| 2010-04-30 15:49:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ac7e891b68063f3a41f3b3ba8c8ab7a5 |
Commitments Test Entity - Third Quarter Report
|
| 2010-06-01 09:45:00 |
Prana to Present Findings at American Aging Assoc Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6bdec6b7b4a524285c2f5d9032a962ad |
|
| 2010-06-08 16:53:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/804b6805eac18308c5d699d268ffdb25 |
|
| 2010-06-21 10:39:00 |
Review of the Role of Metals in Alzheimers Disease |
0 |
https://app.sharelinktechnologies.com/announcement/asx/971c51b4d0f17cea9f3f1b15a92aa8a2 |
|
| 2010-06-28 09:24:00 |
Investment by Quintiles, Placement of 225 million Shares |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d3085c8983d5c18f21eed0819769c6b6 |
Security holder details - Other
|
| 2010-07-01 10:01:00 |
New PBT2 data in 2010 Hot Topics Session |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9cc7734daf4a7b8bfc46a57c0968db44 |
|
| 2010-07-19 09:46:00 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/20e4695382dfb23c6572112e6c1046cd |
Notice of General Meeting
|
| 2010-07-19 11:46:00 |
Pranas Research Presented at Alzheimers Disease Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/99dd5b26144d7892e73dee736413c562 |
|
| 2010-07-19 17:01:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b9c0f03f5ec3b1b744897c9c35235c73 |
|
| 2010-07-30 16:52:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/55ff0daad8db6c85193d0b949fc4f037 |
Commitments Test Entity - Fourth Quarter Report
|
| 2010-08-03 09:27:00 |
Prana Cited in New Scientist Magazine Article |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4f9d6b16b4bd4714129e80fd2f49bee8 |
|
| 2010-08-17 12:12:00 |
Results of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7579533ee94ca2b8263203bfaf357dd8 |
|
| 2010-08-24 09:57:00 |
Prana secures key PBT2 patents in the US and Europe |
1 |
https://app.sharelinktechnologies.com/announcement/asx/448cf865a45a12918e1b8a522ab95c1e |
|
| 2010-08-27 11:24:00 |
Appendix 4E for the Year Ended 30 June 2010 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0161d526a5234815d2548cdafa756a3a |
Full Year Directors' Report
|
| 2010-09-03 09:39:00 |
Cell publishes critical role of metals in Alzheimers Disease |
0 |
https://app.sharelinktechnologies.com/announcement/asx/78f399419f151a8d06d68711f08c11ec |
|
| 2010-09-27 17:20:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9a595faafe196bd5858ca3ea6c667e1d |
|
| 2010-09-29 09:55:00 |
Prana selects lead PD drug candidate for development |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9737725720e6fa0ef8d8453782f0b933 |
|
| 2010-09-30 17:59:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5b5bd301f57c3e9ecb3884ae63865f03 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2010-10-08 17:39:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/255131163ff305a0c6ed28480d183dc5 |
|
| 2010-10-22 10:15:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f24430867cfb5e1a8f8c00288c69cdf9 |
Notice of Annual General Meeting
|
| 2010-10-27 17:48:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a8663b9baa42bed4d44321b28a565593 |
Commitments Test Entity - First Quarter Report
|
| 2010-11-03 17:19:00 |
Appendix 3Y - GK, GM, BM, PM, PM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7375754f94ae33cd5a1425e68a4886da |
Change of Director's Interest Notice
|
| 2010-11-04 17:09:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/02e4ca7a4cfef08a1d8387cc37a0bade |
|
| 2010-11-04 18:16:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b4e19a215ccb61887f28e506fec0a67d |
|
| 2010-11-04 18:16:00 |
Trading Halt Request |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a193a18b4531ed5eac8eda4e720be53a |
|
| 2010-11-08 13:20:00 |
Prana plans to advance Alzheimers clinical trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cd10682b83fd3e14f63cf84f044e803e |
Company Administration - Other
|
| 2010-11-10 09:47:00 |
Form 20-F |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6c7ffde4218dde8f74209415a1c94f64 |
|
| 2010-11-11 09:48:00 |
Broadcast on plans to advance Alzheimers Clinical Trial |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e269c0b032e6a8ad7fbae87fe9f68d14 |
|
| 2010-11-26 12:09:00 |
Results of 2010 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/235ea3ebf75325a2ff45033f01748957 |
|
| 2010-12-03 09:56:00 |
Appendix 3Y - Paul Marks |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7e404fc22d7b88d5eb9ad5f2924bf105 |
Change of Director's Interest Notice
|
| 2010-12-22 15:15:00 |
Securities Trading Policy |
0 |
https://app.sharelinktechnologies.com/announcement/asx/229469b166cb452d46024660b5b6ade0 |
|
| 2011-01-04 09:28:00 |
Resignation of Non-executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f90549955d29854d296ef72233b00673 |
Director Appointment/Resignation
|
| 2011-01-04 17:07:00 |
Appendix 3Z - Paul Marks |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dabc806f1908bb99edd441f6b139b08d |
Final Director's Interest Notice
|
| 2011-01-28 17:50:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8a1832ba6d8a9f2af787602820b10125 |
Commitments Test Entity - Second Quarter Report
|
| 2011-02-18 13:31:00 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c50fb4c97a7a2abcbf22c633d0728c87 |
|
| 2011-03-01 08:36:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/84b07b275069dbc061a174ede2a13ba1 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2011-03-04 09:39:00 |
Prana`s Co-Founding Scientist Awarded Prestigious Fellowship |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4a12df9d0ce0e5272d154935d92dc003 |
Company Administration - Other
|
| 2011-03-04 16:57:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/02c9b0ce4a9f3fe03e3169077f031c13 |
|
| 2011-03-09 14:44:00 |
Prana to Present at Cowen and Company Health Care Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/588f82b1efe046c13a2ebcb16c5840c9 |
|
| 2011-03-15 09:25:00 |
Lead Parkinsons Drug Presented at International Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/790d4116ba148768fa596a4dcb65e788 |
|
| 2011-03-21 11:39:00 |
PBT2 - Directly Restores Neurons Critical to Cognition |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0b5346ff77f42f87518bee1966a7577b |
|
| 2011-03-23 14:10:00 |
Prana Raises A$6.19 million in a Private Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e878cfdae74e255abae2b1104229b711 |
|
| 2011-03-25 12:53:00 |
Form 6-K - Placement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/410bc72a63aa089bbcaea6f66b7f1235 |
New Issue Letter of Offer & Acc. Form
|
| 2011-03-31 11:14:00 |
Prana`s PBT2 Phase II trial receives funding from ADDF |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5e07328bdde5e7f34e37f5ed17bc825c |
|
| 2011-04-01 09:29:00 |
Form 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8176dc6a876cbff031c7e01a93b3ace5 |
|
| 2011-04-08 16:33:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/677bf7001aedf0abf8961ce698119add |
|
| 2011-04-11 09:55:00 |
Form F-3 - Registration Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/56d508b029119198b5329b7e117706ae |
|
| 2011-04-11 11:36:00 |
Prana secures key PBT2 patent in Japan |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f78b6142da900f858e7a2a266e386556 |
|
| 2011-04-20 09:42:00 |
Prana accelerates PBT2 commercial development |
1 |
https://app.sharelinktechnologies.com/announcement/asx/08160ad8b90d6d9bac80d506bbda42b3 |
|
| 2011-04-28 12:22:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3caec8e9c03f75c8b6d4502da7a7ab72 |
Commitments Test Entity - Third Quarter Report
|
| 2011-05-12 09:48:00 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/828e5af6e10b66c6531f0a946dd975cd |
Notice of General Meeting
|
| 2011-05-18 09:35:00 |
Form F-3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8211a92e33bd9df3dc2a538d72794784 |
|
| 2011-06-08 09:44:00 |
Prana`s Scientists Present Findings World Pharma Congress |
0 |
https://app.sharelinktechnologies.com/announcement/asx/91a8bb0a94cef065ddd7971c5fc2c280 |
Chairman's Address - Other
|
| 2011-06-10 11:18:00 |
Results of 2011 General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7e7161df62a2ac38110d2c12d68f1a3e |
|
| 2011-06-28 09:53:00 |
Prana`s PBT2 presented at HDSA National Convention |
0 |
https://app.sharelinktechnologies.com/announcement/asx/274c95066dfdf1186eebc6da633ae534 |
|
| 2011-06-30 14:17:00 |
Quintiles Makes Second Investment in Prana |
1 |
https://app.sharelinktechnologies.com/announcement/asx/250f95d6dd430549b5d92c415aa2228d |
Security holder details - Other
|
| 2011-07-01 14:19:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ba36604af1875ddfa0453beb1968784a |
|
| 2011-07-01 16:40:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6fa05bb5757296d4fb21ddb6d9ab91b3 |
Change in substantial holding
|
| 2011-07-04 14:50:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/15b12c6aa7b5134885cd301a68617ab7 |
Change in substantial holding
|
| 2011-07-14 09:35:00 |
Prana Announces At-the-Market Issuance Program |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ebc3870165e679a6d64bebe3f4363344 |
|
| 2011-07-14 09:44:00 |
Form 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/717d7208dede67d4dc0653647fbd6b3d |
|
| 2011-07-14 09:48:00 |
Prospectus Supplement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e9a1126f503b1601b1b69af568596189 |
|
| 2011-07-21 17:29:00 |
PBT2 presented in a Plenary Lecture at ICAD in Paris |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5cd88c3f63698a5bac88cfd2d0675166 |
|
| 2011-07-27 16:15:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b05150896466c3ad25eb6ce30f2db369 |
Commitments Test Entity - Fourth Quarter Report
|
| 2011-08-08 12:36:00 |
Leading Investor Lawrence Gozlan Joins Board of Directors |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2702fb55a273d67762d5cc939b67d725 |
Director Appointment/Resignation
|
| 2011-08-09 10:20:00 |
Appendix 3X - LG |
0 |
https://app.sharelinktechnologies.com/announcement/asx/386c71468c655bc709730e169c75c36b |
Initial Director's Interest Notice
|
| 2011-08-19 18:26:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fbfe43c3454d93be5f160f3e1779069b |
Ceasing to be a substantial holder
|
| 2011-08-22 09:48:00 |
Prana Receives Michael J. Fox Foundation Grant |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5a18ea57ab052c9703177dfdffd5504d |
|
| 2011-08-25 17:23:00 |
Appendix 4E - Preliminary Financial Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5852817de50be26ae71e0b16f39449f4 |
|
| 2011-09-06 09:54:00 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/87a4d3cd99e12e084fcd6e16481ce10b |
Notice of General Meeting
|
| 2011-09-12 16:10:00 |
Trial presented at World Congress on Huntington`s Disease |
1 |
https://app.sharelinktechnologies.com/announcement/asx/22b82eb6e1e03f53bd5e2d39f7a17207 |
|
| 2011-09-14 09:23:00 |
World Congress on Huntington`s learns about PBT2`s Promise |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8d97c2847d1053caba757ca193de1521 |
|
| 2011-09-16 09:18:00 |
Planned Huntington`s trial receives strong interest |
0 |
https://app.sharelinktechnologies.com/announcement/asx/defc50c904c4824f6c5be68409b04610 |
|
| 2011-09-19 09:03:00 |
Prana`s PBT2 Directly Restores Neurons Critical to Cognition |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b405d7b97094a62011003b1a0dffbe45 |
|
| 2011-09-19 15:50:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/604f94fd6b028efddc732b28c1793896 |
|
| 2011-09-21 13:08:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/010ab3d46d2fc901e2b423666cbd23b4 |
|
| 2011-09-22 12:37:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4bd0e29d1e24b5dcb3e297ff4a103c2b |
|
| 2011-09-23 17:27:00 |
Annual Report 2011 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2558a860564233ca023b0960931ae5f6 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2011-10-03 09:15:00 |
Form 20-F |
0 |
https://app.sharelinktechnologies.com/announcement/asx/74543592a29ea0d8ade2e3c9bae06b8e |
|
| 2011-10-07 11:57:00 |
Results of 2011 General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/754442397ba7698ce073b4b28e7c1afa |
|
| 2011-10-20 11:26:00 |
Government Grant to Study effect of PBT2 in the ageing brain |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0eca19fa30b74e595ba096e1a0b92c7e |
|
| 2011-10-27 15:25:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/76f4546fb8d9f095b61be06d124aa339 |
Commitments Test Entity - First Quarter Report
|
| 2011-10-27 16:12:00 |
Australian Government funds study into benefits of PBT2 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/758ea92c2190aafafebf741acebfa92e |
|
| 2011-10-28 09:36:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bb52678100fd4e54a5276358a56c9fe6 |
Notice of Annual General Meeting
|
| 2011-11-14 14:17:00 |
PBT2 reverses the loss of synaptic activity in neurons |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fbf39b2e87e2a17353dc923c798b5e63 |
|
| 2011-11-21 10:46:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c8d41f5f04c763b9e929819699957a8f |
|
| 2011-11-22 09:28:00 |
Prana Receives Approval For Alzheimer`s Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1492997eb100d045b04d0034b3fc0ff6 |
|
| 2011-11-25 10:13:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ab6c6181f973e83ca5abf82bbefe4f5d |
|
| 2011-11-28 14:55:00 |
Key Patent for Parkinson`s Drug PBT434 Secured in USA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1cf6d95b036390819e8e7fd7066f96fc |
|
| 2011-11-29 12:05:00 |
Results of 2011 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7bd2d7ba085b9bbdca28258b6eb0ad8c |
|
| 2011-12-15 13:56:00 |
Prana Commences Alzheimer`s Trial Recruitment |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f5c67baa153d61f7b5c547c3f53a62a9 |
|
| 2011-12-16 10:08:00 |
Landmark Publication Endorses Prana`s Strategy |
1 |
https://app.sharelinktechnologies.com/announcement/asx/678212a808e1f39a53b854d8ff6bc778 |
|
| 2011-12-20 08:30:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5cb8f782dcedf610d35baf6c17243b0f |
|
| 2011-12-22 16:20:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/85593e1b010adfa50127f6bedfde2dc7 |
|
| 2012-01-04 09:58:00 |
FDA Approval to Commence Huntington`s Disease Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c75498420e565c0d9446dae49b12b14e |
|
| 2012-01-04 17:21:00 |
Change of Director`s Interest Notice - GK |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a7dba9e9217303244a5461abe0247e72 |
Change of Director's Interest Notice
|
| 2012-01-09 18:11:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/39357da959d2fdeff2cb76e91bbcae5b |
|
| 2012-01-10 11:15:00 |
Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/03f262a7695e6b338d0505935fcae70b |
|
| 2012-01-11 09:21:00 |
Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f51596dfe60302dcd1b2c120b69b6e65 |
|
| 2012-01-11 09:32:00 |
Professor Tanzi Appointed Prana`s Chief Scientific Advisor |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4a68280b183942869d046e64cc9e480b |
Company Administration - Other
|
| 2012-01-17 09:46:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/76233521b3565f5b195d78dcd0b6d13b |
|
| 2012-01-30 09:42:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/45ea4070125d515aecc2675e6c9277e1 |
|
| 2012-01-31 16:14:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bb8a358ba7bb3f33579ea1b2af34176b |
Commitments Test Entity - Second Quarter Report
|
| 2012-02-01 10:51:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6016c66ae1e673ac962909bbb450c130 |
|
| 2012-02-01 11:28:00 |
Prana Diversity Policy |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8534cb05eb50fae3effeb5d1148da934 |
Company Administration - Other
|
| 2012-02-02 15:50:00 |
Prana comments on articles |
0 |
https://app.sharelinktechnologies.com/announcement/asx/330cb2db7fe3ea7271287881d08104ea |
|
| 2012-02-07 11:36:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/839da06f4138d13724fdb850162423b7 |
|
| 2012-02-08 09:52:00 |
Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ad176d814c259a306d97b47e18dcdc4f |
|
| 2012-02-09 09:38:00 |
Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1a49abf375e8487b9579faeea73087f6 |
|
| 2012-02-10 09:37:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/84433c018fd8f958083c3ea47613e78c |
|
| 2012-02-16 11:01:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3d66d7bcd04cfd58a11014e78ce7c17e |
|
| 2012-02-24 12:25:00 |
Appendix 4D |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f0e2fcb4932976ef1a717f421eda0ddb |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2012-02-27 09:42:00 |
Form 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cecda2daa472c04213e9842cbe33fa70 |
|
| 2012-03-01 09:45:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/824155ab06ae5f544ad2ed57abddc6ac |
|
| 2012-03-06 14:11:00 |
Prana Doses First Patient in the IMAGINE Phase II Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a9c4ac00b3d34c6241dca60709319f41 |
|
| 2012-03-21 09:53:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4375f8e13cef6e908a8371e263480cce |
|
| 2012-03-26 10:47:00 |
PLoS ONE Journal Publishes Model of Alzheimers Disease |
0 |
https://app.sharelinktechnologies.com/announcement/asx/94522b42328c4a3d7c4f0341fb4ffd59 |
|
| 2012-03-29 11:19:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ba4023afa5053637a63143826bc3edb7 |
|
| 2012-04-17 11:57:00 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ca3087a283c8540fb1901fd4bcb5bb3f |
Notice of General Meeting
|
| 2012-04-27 17:34:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7758aa2c4dfade092ce3b21cc5d040f5 |
Commitments Test Entity - Third Quarter Report
|
| 2012-04-30 10:06:00 |
First Patient Enrolled in Phase II Huntington Disease Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e66c8940c3c096e4ec267a3d3f08a397 |
|
| 2012-05-01 14:27:00 |
Prana Comments on Neurology Publication Huntington Data |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e8ffbaa07d7e1b207c6ebad4bfa5384f |
|
| 2012-05-04 11:28:00 |
Change of Director`s Interest Notice - GK |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6634d76f81de00b79ce057603427dd7d |
Change of Director's Interest Notice
|
| 2012-05-09 14:06:00 |
Dr. Rudy Tanzi to Discuss PBT2 Trial on Thursday, May 10 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/200dd14caa4098a70751907580206e91 |
Company Administration - Other
|
| 2012-05-18 11:31:00 |
Results of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4e565473e3b23894d315cc28d5ff902e |
|
| 2012-05-21 11:30:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4d772e549b5ad614330270f8004b57f3 |
|
| 2012-05-25 09:25:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/13fb2baf6b3ca2104e0343283ffaace4 |
|
| 2012-06-01 09:41:00 |
Prana to present at upcoming Australia and US conferences |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8a427b20cfaf2de90def8aa6adec41c8 |
Chairman's Address - Other
|
| 2012-06-13 10:02:00 |
Prana`s PBT2 presented at HDSA National Convention |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c2b366bd8a2dfc7af697a5a40a694fee |
|
| 2012-07-31 16:41:00 |
Appendix 4C - Quarterly report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/03e26eaffa1cc659270192df67868d34 |
Commitments Test Entity - Fourth Quarter Report
|
| 2012-08-22 09:34:00 |
Prana Provides Clinical Trials Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cc4ad8ed193323f599057eb45187ce4b |
|
| 2012-08-22 14:00:00 |
ABC Radio Program features Prana Alzheimer's disease trial |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7bcb4c6c8f7e3ea0ce87b291700231c6 |
|
| 2012-08-27 12:43:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/298c5c0a5c7b7b76c022528cef678df4 |
|
| 2012-08-30 09:50:00 |
Prana's Parkinson's drug meets development milestone |
1 |
https://app.sharelinktechnologies.com/announcement/asx/14be5cc5cf0e7ebb845d3a53174cec2f |
|
| 2012-08-31 16:47:00 |
Appendix 4E - Preliminary Financial Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c56c75ed41099cd077de902abbf73ce9 |
|
| 2012-09-03 09:39:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0dbbe4bbed1fc6ad8ad0cfa8e4f9b957 |
|
| 2012-09-11 10:02:00 |
Significant Promise in the Fight Against Alzheimer's Disease |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d0152d359d724edb36b3119dcfce399d |
|
| 2012-09-12 09:59:00 |
Prana Receives Recommendation to Proceed with Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b7be65de11ec731184b75cf5db538394 |
|
| 2012-09-17 09:37:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/360efd1ac9ec844656c4e77b9c7f28b3 |
|
| 2012-09-20 09:27:00 |
Prana's PBT2 Clinical Trials Cited as Most Advanced |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6b63a4cdbe018b0c3c18cb7e55fd2bdf |
|
| 2012-09-20 14:48:00 |
Further information - Clinical Trials Cited as Most Advanced |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e11cc36d00689b45e3270d7caf532aa9 |
|
| 2012-09-26 10:40:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/67273911378805d35180046a454329fd |
|
| 2012-09-28 14:01:00 |
Prana Scientist to Participate in Webcast |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6ed8372ee4563a518568e6f6d2f3c265 |
|
| 2012-09-28 16:23:00 |
Annual Report 2012 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/120f6ab90106811d5faafdac4d8b0fe9 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2012-10-01 09:53:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/63e4c5a9b25a3777f00f247bf96d6e2a |
|
| 2012-10-01 19:31:00 |
Prana Announces A$6.0 Million Capital Raising |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5035a11ab5afedf9674e0b7998c156c6 |
|
| 2012-10-05 10:07:00 |
Form 20-F |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1ce3ef841d568baa4da6c74bbd331bad |
|
| 2012-10-08 09:37:00 |
Revised table in 2012 Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/654de129ac83d11c1304afd0f9ab32ba |
|
| 2012-10-08 09:45:00 |
Appendix 3B and Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b403d1062b9ded4bb96b1f46c8547251 |
|
| 2012-10-09 16:44:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4ae2ca472667b0c3ef229b16c8345b05 |
Change in substantial holding
|
| 2012-10-09 16:44:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/84aea16b2c316b30c2936ec126d7541f |
Ceasing to be a substantial holder
|
| 2012-10-29 16:44:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/937e73ffe09c4f19422fcc6bd6881e2b |
Commitments Test Entity - First Quarter Report
|
| 2012-11-09 15:22:00 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/34fa5d6b70f8e5673f6a40cf384ce9c7 |
Notice of Annual General Meeting
|
| 2012-11-14 14:20:00 |
Prana Provides Huntington Disease Trial Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0e2a918446be2bf78b3579bf19816421 |
|
| 2012-11-20 09:50:00 |
Prana to present at New York Academy of Science Symposium |
0 |
https://app.sharelinktechnologies.com/announcement/asx/684a0aa10a8597273ff13cd53ec9351f |
|
| 2012-11-27 09:30:00 |
Prana Completes Recruitment in Alzheimer's Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e74dce0f44e7a5cc05d40ddef64ab91b |
|
| 2012-11-30 15:48:00 |
Response to ASX Diversity Policy |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f07eb531e488d09799f010b19c85021 |
|
| 2012-12-06 11:39:00 |
New York Academy of Sciences Symposium Discusses PBT2 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6bffb2d0c739b8268674f3af1789f468 |
|
| 2012-12-12 10:45:00 |
AGM Presentation 2012 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d61efef2d2ef04506da7c21a0fd1f194 |
Chairman's Address to Shareholders
|
| 2012-12-12 11:41:00 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4fc77614acf174641ef9ef5d703c5627 |
|
| 2012-12-12 19:05:00 |
Appendix 3B and 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f048c59c71864d27b4826d87db0df5d8 |
Alteration to issued capital
|
| 2012-12-12 19:06:00 |
Change of Director's Interest Notice (GK,GM,BM,LG,PM) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3ade09d742b4b0c94000a09d934bf955 |
Change of Director's Interest Notice
|
| 2012-12-13 10:19:00 |
Journal of Huntington's Disease Publishes Benefits of PBT2 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/956b6ee6c4a1fcbea75c79b92aa518ac |
|
| 2012-12-19 09:42:00 |
Prana Completes Recruitment in Huntington Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2bc58fcb3f7229eae22f321c9cee3a11 |
|
| 2013-01-30 09:07:00 |
Prana Announces NYAS Symposium eBriefing Available Online |
0 |
https://app.sharelinktechnologies.com/announcement/asx/07b5c6a6e7e798d5aa72e63dfaa3a7b8 |
|
| 2013-01-31 16:23:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c418e2cf55064f2ec60205ca4fd56aa9 |
Commitments Test Entity - Second Quarter Report
|
| 2013-02-26 11:23:00 |
Prana to Present at Cowen & Company Health Care Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/56b47b0aca98c2414df1052ed5bb1fee |
|
| 2013-02-27 16:24:00 |
Appendix 4D |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c11e81a2cb9ab447821cc1f26de55ef2 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2013-02-28 09:45:00 |
FORM 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/27de85c589c7f11a4884a54ec01b3f0f |
|
| 2013-03-04 15:12:00 |
Prana's PBT2 Reduces Tau Related Cognitive Impairment |
1 |
https://app.sharelinktechnologies.com/announcement/asx/828994122468933794d569adc6517994 |
|
| 2013-03-06 10:29:00 |
Pranas PBT434 Inhibits PD Protein & Brain Cell Death |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5789849d0f90e7e88aacf389bb274b51 |
|
| 2013-03-07 09:57:00 |
Response to ASX Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c7af9de57150d6d3da5059430ac013b0 |
|
| 2013-03-07 17:48:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6fdbca3e9febcf06ef8456b825d4b187 |
|
| 2013-03-08 16:33:00 |
Prana details PBT2 data on reduced Tau Cognitive Impairment |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0a007e56678140815a753174c1492f71 |
|
| 2013-03-27 09:03:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5b929c5c7a676ce30ff982fc15a23c56 |
|
| 2013-03-27 19:10:00 |
Prana Announces Successful A$7 milion Capital Raising |
1 |
https://app.sharelinktechnologies.com/announcement/asx/043f32cd1ccc7dc45f5ebc4f209726d2 |
|
| 2013-04-03 16:13:00 |
Prana Provides Clinical Trials Safety and Progress Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/299daf1f4bed7553cd74565514873951 |
|
| 2013-04-04 15:45:00 |
Prana announces $5.8 million R&D refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b443278574b4b0e62bc592234b9592a2 |
Company Administration - Other
|
| 2013-04-08 19:08:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7c9f2c4f677cdfbcaf9da72e1a1ce264 |
|
| 2013-04-11 17:13:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1df32a12c8346e05c68642cb393046d4 |
Ceasing to be a substantial holder
|
| 2013-04-11 17:18:00 |
Share Purchase Plan 2013 Offer Document |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c762d9d1629b0212371bda30607222e6 |
|
| 2013-04-29 17:03:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/11e673c0c55d453979ba2d02cdb58eba |
Third Quarter Cashflow Report
|
| 2013-05-03 17:35:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2980d1e47a7aa7fc2381664a550468ff |
|
| 2013-05-03 17:44:00 |
Prana Announces Share Purchase Plan Closed |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6f7f67eeb06dde98a01fb2b4b58d3747 |
|
| 2013-06-19 12:17:00 |
New benchmark test to assess HD patients in clincial trials |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f2b81b3638c9c3fb85da5fab12ad5bbe |
|
| 2013-06-20 14:25:00 |
Pranas PBT434 shows potential as treatment in PD |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ae52407282a8e70bc34b1a9b71575aa2 |
|
| 2013-06-28 16:57:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c8f16a8aaddaee04d988b350479f0c49 |
|
| 2013-07-03 14:18:00 |
Prana receives approval for open label extension study in AD |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f2bc082fe96a943c01c463139d64b370 |
|
| 2013-07-23 10:32:00 |
Prana Completes Phase 2 Huntington Disease Trial with PBT2 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6554938f7704b27d14b5d7c30c6f87af |
|
| 2013-07-29 09:47:00 |
Prana Doses 1st Patient in PBT2 Alzheimers Extension Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ea364dd3d7692826668c5121920fb0d7 |
|
| 2013-07-31 16:31:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8d06095846f9939b4c846a57cd309d78 |
Commitments Test Entity - Fourth Quarter Report
|
| 2013-08-02 09:24:00 |
Prana prepares for next steps in the PBT2 development path |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a58be6ebc32076ff2bdd7ce747e73981 |
Company Administration - Other
|
| 2013-08-05 16:58:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/729e173fc884a6b8815218f9dc0692f6 |
|
| 2013-08-06 10:20:00 |
Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3fcbb2e14ac8210d8b4fabde6cc212db |
|
| 2013-08-07 09:36:00 |
Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/97a25f0c0d49e30db5ab56b889b5c818 |
|
| 2013-08-26 09:14:00 |
Response to ASX price query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5900f7cd445d15b2805e8ddba1517118 |
|
| 2013-08-30 13:58:00 |
Appendix 4E Preliminary Final Report and Statutory Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ab9457b8bb179fd17395e8826556657e |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2013-08-30 16:29:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d2183af1a507a3968ca43b561bbf72ce |
|
| 2013-09-02 09:25:00 |
Form F-3 - Registration Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/03ca1a87a4d32928473e125311ef6b5f |
Company Administration - Other
|
| 2013-09-02 09:29:00 |
Prospectus Supplement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0e1876e229265e4bdd25bef60df40c1a |
|
| 2013-09-02 09:31:00 |
Form 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6a4daf7b7bf001e6f411f71af0676c90 |
|
| 2013-09-03 11:03:00 |
Prana's PBT2 named one of Top Neuroscience Projects to Watch |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c3f0f82c8ee749bfec655c18866757d8 |
|
| 2013-09-04 09:44:00 |
Parkinsons UK Awards GBP150,000 to Study Pranas PBT434 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/33c21ab58b2cc1fa0003010dab54d577 |
|
| 2013-09-10 10:42:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/385616c1fd5051ba1113dc6a4d5c8cfd |
|
| 2013-09-11 09:29:00 |
Section 708A Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2d3ce9c4179efa902f6bdab4272c1266 |
|
| 2013-09-12 10:18:00 |
Section 708A Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1e28e7cc09b4af364c8d8c2b7a71e383 |
|
| 2013-09-13 11:47:00 |
Prana Updates Progress on PBT2 Trials |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9b584bcea5390787aa1a19639b08f38c |
|
| 2013-10-01 09:58:00 |
Annual Report 2013 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/468c9a871a0f48ffab5c98f54d42eb00 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2013-10-03 17:36:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/de0d8936234a839f6731efedeac81b2d |
|
| 2013-10-23 08:28:00 |
Form 20-F |
0 |
https://app.sharelinktechnologies.com/announcement/asx/20298053a2ffe455fcc52756d9a01cef |
|
| 2013-10-24 10:02:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/11844ff432a6f50698d17d0f68046660 |
Notice of Annual General Meeting
|
| 2013-10-24 14:29:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dacd90690ef25d7c8e2f3a35aa24c076 |
Commitments Test Entity - First Quarter Report
|
| 2013-10-25 16:16:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bccb8cc1b74a4faac792b062fdd4c62e |
|
| 2013-10-31 09:22:00 |
Prana's PBT2 Reverses Memory Loss in Normal Aging |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e5eaa6f04429ddc48efd0dc445932013 |
|
| 2013-11-04 15:58:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/508d3726336c43616ca508e17acba5e4 |
|
| 2013-11-05 19:22:00 |
Section 708A notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d3cda2d674ab81a02f292568ba0321cc |
|
| 2013-11-06 10:21:00 |
Section 708A Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/74fd59ab10d1da5a9c6cb42666fb8845 |
|
| 2013-11-15 15:35:00 |
Prana responds to media segment under ASX Guidance Note 8 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0737a35be16496f4378662a9bc83a48f |
Company Administration - Other
|
| 2013-11-18 14:59:00 |
Prana Provides Update on Clinical Trials for Alzheimers |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9a8810678f76021fef9526de6346265a |
|
| 2013-11-19 10:13:00 |
Pranas PBT2 features as a top 10 global neuroscience project |
0 |
https://app.sharelinktechnologies.com/announcement/asx/721afe0b88ef107228a94f2c7bf48ade |
|
| 2013-11-25 15:32:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7c8c7f3308db8aa3507eeac96be13579 |
|
| 2013-11-28 12:13:00 |
Prana AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f73daf53c2aa5dd5ee05ed83a0849d11 |
Chairman's Address to Shareholders
|
| 2013-11-28 12:17:00 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9ee259dff513e0e1b171cf6fb3514e5e |
|
| 2013-12-09 10:25:00 |
Prana completes PBT2 dosing in IMAGINE AD Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9f626a788b9c9c2ca8e38b193be3d738 |
|
| 2013-12-11 08:27:00 |
Prana Provides Update on PBT2 AD Extension trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3b33f653bae6fdb120560fd24fedcc49 |
|
| 2013-12-13 16:56:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5540a797756ab1c10cf9b51cb7988b48 |
|
| 2013-12-23 08:28:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0d46475a9ef943b107c5112e8812d174 |
|
| 2014-01-03 18:52:00 |
Appendix 3B and 708A notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eb4ca6af7fb2e0d16329e5d8f6ef6a49 |
|
| 2014-01-22 10:08:00 |
Prana commences US Investor Roadshow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bfeb8e819b6f54c6a404de2fe334cd56 |
|
| 2014-01-28 16:48:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b44bac900aae5a4a697dc23acb2ca466 |
|
| 2014-01-31 17:19:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c3fca66205ae979d5fe4ff7d5de1e54b |
Commitments Test Entity - Second Quarter Report
|
| 2014-02-03 10:19:00 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/75265f6088027c616e9da07b8880d9ed |
|
| 2014-02-07 16:30:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f2918e5f8e4caeb49c58fdabd5a71c3c |
|
| 2014-02-17 09:05:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/359c299bf163239c2f8cd63d70d2f903 |
|
| 2014-02-18 15:32:00 |
Prana Biotechnology REACH2HD Investor Conference Call |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3a298f504ce402bbad7673d57002e145 |
|
| 2014-02-18 17:03:00 |
Prana Announces Successful Phase 2 Results in HD Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fc85878a35d760b9934a0e7398dd140b |
|
| 2014-02-19 09:46:00 |
Investor Conference Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee52915c97d574f3636e80b06ec592ac |
|
| 2014-02-26 16:54:00 |
Appendix 4D Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4064d3726bf5fae16047af8a40fab03f |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2014-02-26 17:02:00 |
Commentary on Half Year Financial Results |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4d1969017ba4873f1e3e417a5268bcc0 |
|
| 2014-02-26 17:07:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/24d1f6878aa735f0f937159fa5c0a015 |
|
| 2014-02-27 09:18:00 |
Form 6K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48643c0a56179f61c4b18bb3c1183f37 |
|
| 2014-03-03 15:56:00 |
34th Annual Cowen Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fbdb82d8ab1e02f33308ecf488dd5a6d |
|
| 2014-03-03 16:18:00 |
Prana Presents at 34th Cowen Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/415d99a726f1f0d952d66be11c5c6fbf |
|
| 2014-03-06 13:03:00 |
Pranas Alzheimers Disease Treatment Strategy Validated |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c1b3936b65e8dfcfa15d8b3260663013 |
|
| 2014-03-07 09:03:00 |
S&P DJ Indices Announces March Quarterly Rebalance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/26c467ade398a233226d9295a210bf77 |
Standard and Poor's Announcement
|
| 2014-03-11 16:29:00 |
Prana Biotechnology admitted to S&P / ASX 300 Index |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d8fb300eac93dfab87b6b34cea49fc99 |
Standard and Poor's Announcement
|
| 2014-03-11 18:13:00 |
Prana Biotechnology admitted to S&P/ASX 300 Index -corrected |
0 |
https://app.sharelinktechnologies.com/announcement/asx/385795487d4324498f56f2a2171d9c87 |
Standard and Poor's Announcement
|
| 2014-03-13 17:24:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/11cfbfb4b2f687d9703d6bd763151ed0 |
|
| 2014-03-31 10:09:00 |
Company's Request for Trading Halt |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b4407aa8bf04fb924f7ab678f7352d2c |
|
| 2014-03-31 10:09:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7501408078d961ef393241da3d18f94b |
|
| 2014-03-31 20:55:00 |
Prana announces preliminary results of Alzheimer's Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/75fa6714770a89077dbf8a7dfc843f76 |
|
| 2014-04-07 17:37:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5238430748b51a99910659ebbd77a566 |
|
| 2014-04-24 17:58:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bba18a04ec4fd1d9c629bcb254c35d31 |
Commitments Test Entity - Third Quarter Report
|
| 2014-05-13 15:24:00 |
Movement disorders expert joins Prana Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b11a67dc679675fcb46ad82331c817f1 |
Director Appointment/Resignation
|
| 2014-05-14 14:31:00 |
Interview - Professor Ira Shoulson joins Prana Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dda823a87890c8fee0d5ea145bd435c8 |
|
| 2014-05-16 17:01:00 |
Initial Director's Interest Notice - IS |
0 |
https://app.sharelinktechnologies.com/announcement/asx/435a1d3288e7af7ea16b5ce847eeee72 |
Initial Director's Interest Notice
|
| 2014-05-28 15:11:00 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bff96f6f99ca3a901fac2206af128bae |
|
| 2014-07-17 16:02:00 |
Prana Alzheimers disease Development Program update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/31490b2bf9b83fcb0144ac139fcb32b3 |
|
| 2014-07-25 10:51:00 |
Form F-3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/247331a605aa517cff2614eb22b37cf2 |
Company Administration - Other
|
| 2014-07-31 12:19:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/95882deee483659a1eb2939c50a6b626 |
Commitments Test Entity - Fourth Quarter Report
|
| 2014-08-07 18:16:00 |
Appendix 3B and 708A notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4adc25eeeb9fa8ecf4bebf430694c331 |
|
| 2014-08-29 17:17:00 |
Appendix 4E & Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/00d8ad3af594a71112bc0807cee874fd |
|
| 2014-09-05 10:21:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1ff4c175595aa7a1562850044a492cf0 |
|
| 2014-09-05 13:33:00 |
FDA Orphan Drug Designation for PBT2 for Huntington Disease |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c154e72a48f956317eae20ff22918fae |
|
| 2014-09-30 15:47:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1b42e39bf79a36a39f3b28855a4d5cf2 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2014-10-03 17:21:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2e8bd6dd4b39a7f8b3a847ec05a77798 |
|
| 2014-10-13 17:40:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f8f68faad3f03b4d6392db05b37f2d41 |
Notice of Annual General Meeting
|
| 2014-10-24 15:45:00 |
AGM Resolution 4 Withdrawn |
0 |
https://app.sharelinktechnologies.com/announcement/asx/98870ae77e386ad3c370a6f666c6aa9e |
Alteration to Notice of Meeting
|
| 2014-10-30 17:41:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0b2fc359401762878684e59951ca2fff |
Commitments Test Entity - First Quarter Report
|
| 2014-11-04 08:27:00 |
Form 20-F |
0 |
https://app.sharelinktechnologies.com/announcement/asx/24ac7f4855841bc567f283d259c57d88 |
Full Year Directors' Statement
|
| 2014-11-04 09:03:00 |
Form F-3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/27c80ad4311ed96ebf59f32da73fd9f7 |
|
| 2014-11-04 10:17:00 |
Appointments and Change to Office Details |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d9311017ab2c40d6846164699b10a2b5 |
Details of Registered office address
Company Secretary Appointment/Resignation
Company Administration - Other
|
| 2014-11-11 17:27:00 |
Annual General Meeting Conference Call Access |
0 |
https://app.sharelinktechnologies.com/announcement/asx/433053c9d15eaa230606348e172929eb |
Notice of Meeting - Other
|
| 2014-11-12 08:26:00 |
Form F-6 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a4a2cb9857b10bcbcd8e6865fbed2255 |
|
| 2014-11-13 13:28:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a4ffccef8013df05df85613f4592643d |
|
| 2014-11-18 12:46:00 |
The Lancet Neurology publishes Prana's HD Trial |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f461e9c22d7f3536f54440623cd37de6 |
|
| 2014-11-27 09:51:00 |
Prospectus Supplement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a997e0d699beba3520f964b0d3bfb357 |
|
| 2014-11-27 09:52:00 |
Form 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f1f83d8dc299d91e96db14ca086e0cc |
|
| 2014-12-12 09:02:00 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b63c947b29e8ff5eed291c4bcb04e92a |
|
| 2015-01-30 11:51:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f573c081cf23b9e945cc512d9b5c1e79 |
Commitments Test Entity - Second Quarter Report
|
| 2015-02-13 09:37:00 |
FDA End-of Phase 2 Status Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/49e99ea81cc5d17b7fddbd65303d9f42 |
|
| 2015-02-19 09:56:00 |
Appendix 3B and s708A notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/76019ccac800a83f1839bb6385e870e4 |
|
| 2015-02-24 17:35:00 |
Appendix 4D Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fd798e371b7ffba6267ee4e4270650de |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2015-02-25 08:15:00 |
Form 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1716bca670bd3d6a87f8fb66d914c9e6 |
|
| 2015-03-06 08:44:00 |
S&P DJ Indices Announces March Quarterly Review |
1 |
https://app.sharelinktechnologies.com/announcement/asx/25576be7a177b65b617bfba6896de86c |
Standard and Poor's Announcement
|
| 2015-04-28 10:21:00 |
PBT2 recommended for orphan designation in Europe |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8b52abafb175041c2ae8127a5d9e5a35 |
|
| 2015-04-28 11:45:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cefe0d5749556a66f30b8eaef4c5b200 |
Commitments Test Entity - Third Quarter Report
|
| 2015-05-22 08:30:00 |
EMA publishes Minutes Recommending Orphan Drug Status |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7dfca83af7f661ec58e91e9e511250fb |
|
| 2015-05-22 08:38:00 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/19bb14becc407c70e1490e1cbb5c65f2 |
|
| 2015-05-27 17:09:00 |
Appendix 3B and 708A notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a9384fb3f1b1a42c8c3013e6881ff4cd |
|
| 2015-06-01 09:40:00 |
Approval of PBT2 Orphan Designation for Huntingtons Disease |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dbf043f1744f9237fbc4d4bdef33a538 |
|
| 2015-06-01 17:40:00 |
Change of Director's Interest Notice - GK |
0 |
https://app.sharelinktechnologies.com/announcement/asx/217e00f9203572d01b923b06591b21fa |
Change of Director's Interest Notice
|
| 2015-06-19 10:27:00 |
Prana announces $6.8 million R&D refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/74c295decff2dd85d9d2fd97db8dfcd1 |
Company Administration - Other
|
| 2015-06-30 18:38:00 |
Safety Outcomes of Alzheimer's IMAGINE Extension Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6689639019398161a1b4e0bd9487f6ec |
|
| 2015-07-27 14:17:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/33aa819bdf21a72baf545ab0089e3185 |
Commitments Test Entity - Fourth Quarter Report
|
| 2015-08-26 17:29:00 |
Appendix 4E and Annual Report 2015 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d0fc21310b09001ece0e97faeee6e7dd |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2015-08-26 17:39:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f8b4491d18eee89a7ea44184e301e739 |
|
| 2015-08-27 09:41:00 |
Form 20-F |
0 |
https://app.sharelinktechnologies.com/announcement/asx/286585b13fe2ca3af31d37109faecedf |
|
| 2015-08-27 10:10:00 |
Prana reports FY15 financial results |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4daf0bb98db9ceb38dda3d6c956fa118 |
|
| 2015-10-12 11:15:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/acbf0bbdabaf8a5cf4a12337f3c3da1d |
Notice of Annual General Meeting
|
| 2015-10-30 15:32:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/316a71ee3df91f447ee473e54e9d52e6 |
Commitments Test Entity - First Quarter Report
|
| 2015-11-06 16:24:00 |
NASDAQ Deficiency Notice Received |
0 |
https://app.sharelinktechnologies.com/announcement/asx/86d46b94400d414304e5526752e5e7a2 |
|
| 2015-11-10 11:04:00 |
Prana AGM webcast details |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3d5db5c2d5ea8fe4d191d466ad01e60b |
|
| 2015-11-13 09:29:00 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0126a56b87e09939a1d2634a2dfd21bd |
Chairman's Address to Shareholders
|
| 2015-11-13 10:37:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c2f84d7d2c0d62c731c97d24df9136e6 |
|
| 2016-01-29 09:52:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dc27a34cd10e04ce815c89b4727dac1f |
Commitments Test Entity - Second Quarter Report
|
| 2016-02-25 16:59:00 |
Appendix 4D Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/33edc8525573e8b77fea0b4a0ee61807 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2016-02-26 09:29:00 |
Form 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cb6e943e6bf62257231cacd7eb10d765 |
|
| 2016-03-09 18:04:00 |
ADR Ratio Change |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4a91a60ea0eaf1bbc1c29b6366725799 |
|
| 2016-03-11 08:25:00 |
S&P DJ Indices Announces March Quarterly Review |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6cc5c1ed2a52fb8fc8f23d138255ab7b |
Standard and Poor's Announcement
|
| 2016-03-24 17:11:00 |
Prana completes ratio change on NASDAQ |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0469f7f822f08250b5c29ef40d918094 |
Company Administration - Other
|
| 2016-04-11 16:38:00 |
Prana Regains Compliance With NASDAQ Listing Requirements |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ddd105e4f0e36d11b772789e9116bd13 |
|
| 2016-04-22 15:29:00 |
Prana presents at World Orphan Drug Congress |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c9fc1178653721469b25a53e559ac2e6 |
|
| 2016-04-29 13:11:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/98cd3d262764aec0a910115ee93f0ee7 |
Commitments Test Entity - Third Quarter Report
|
| 2016-05-09 09:45:00 |
Prana announces $6.5 million R&D refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e58d0563fa44868fd836e1430fee959f |
|
| 2016-06-14 09:13:00 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7cbea762bfb9f1cbe0566e5958a0fa6d |
|
| 2016-06-22 11:29:00 |
Huntington Disease trial analysis to feature at Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4392f40044a1ce50f58ac0dbe2b2e71c |
|
| 2016-07-27 08:30:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/05ad6fe62f7fca7eb43d6842c639b673 |
Commitments Test Entity - Fourth Quarter Report
|
| 2016-07-27 13:16:00 |
Prana Alzheimer's disease data at world leading conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e6cf36de39431ef92d2741111fa6a333 |
|
| 2016-08-10 09:05:00 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/217042ed73cfdf07c008524457420681 |
|
| 2016-08-26 11:07:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c279f857bef7e046ec47698415d282d8 |
|
| 2016-09-30 13:56:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f18e2a4139fc54c81d9bcb6df6731d74 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2016-09-30 13:59:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3cbeb4c0d70fe5cab48ba40758d1bd5f |
|
| 2016-10-05 10:46:00 |
Form 20F |
0 |
https://app.sharelinktechnologies.com/announcement/asx/60d098c3e88f1e6f456a296184cc2882 |
|
| 2016-10-05 10:53:00 |
Annual Report filed on Form 20-F with SEC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a077b0d45d03fae960e5b5071309a235 |
|
| 2016-10-14 10:26:00 |
Form 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eaa3ec7d5d9f303d3fd344c536bdf33c |
|
| 2016-10-14 10:27:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7191a41bc1ddcebf3241253f01ac7276 |
Notice of Annual General Meeting
|
| 2016-10-14 10:27:00 |
Prospectus Supplement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2e12828a8e2fbc811c883e71695d210b |
|
| 2016-10-18 12:11:00 |
New Reach2HD data presented at American Neurological Assoc. |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8a27e6740761c2f729c9ed83d36af44a |
|
| 2016-10-31 09:21:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c1d1db7d7b7db6bd7bdd6656a0764fae |
Commitments Test Entity - First Quarter Report
|
| 2016-10-31 09:23:00 |
Prana announces $4.8 million R&D refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/07f4d8cd92c2e4399ad13ab6fe817711 |
|
| 2016-11-03 10:19:00 |
Prana provides regulatory update for PBT2 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/77c942ed3d809a4bf8988845032bbf09 |
|
| 2016-11-14 15:21:00 |
Prana AGM Investor Webcast Details |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7a725be927f0319e0027120a141967fd |
Notice of Meeting - Other
|
| 2016-11-17 10:51:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/15316dfd5d8e3f60725aaa97b2a59094 |
|
| 2016-12-23 14:28:00 |
Business Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/daf812638b0a5b51cf40672e0b85159c |
|
| 2017-01-09 10:24:00 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d13cc3ee57d68de844780eedd846514f |
|
| 2017-01-30 10:26:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c2d2b63b17b76046c5d672b02f499d4f |
Commitments Test Entity - Second Quarter Report
|
| 2017-02-24 15:11:00 |
Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b9d5025be8c809be3a4e9437450b4fc2 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2017-02-24 15:36:00 |
Form 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c6ce28ddb1137e8bbb6d4f3b0965bdae |
|
| 2017-03-30 10:47:00 |
PBT434 presented at 13th International AD/PD Conference |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ef071a73298cdbbf0c9b791a82918353 |
|
| 2017-04-27 10:26:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/596a091fb742c1f7960537d6540cd1a6 |
Commitments Test Entity - Third Quarter Report
|
| 2017-06-05 10:16:00 |
David Stamler appointed as CMO to lead Clinical Development |
0 |
https://app.sharelinktechnologies.com/announcement/asx/35ac5b951935bdad1d5ccfd75c6f3746 |
Company Administration - Other
|
| 2017-06-07 16:20:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f3d3f41d7f2433051431ea667879145b |
|
| 2017-06-26 09:52:00 |
Change of address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dfe5aeeabd6dc04b8265535dbb19f451 |
Details of Company Address
|
| 2017-07-03 10:41:00 |
PBT434 Lowers Alpha-Synuclein and Prevents Neurodegeneration |
1 |
https://app.sharelinktechnologies.com/announcement/asx/55ceb8804cc8d71cbfbb5a29d115f064 |
|
| 2017-07-18 10:04:00 |
Prana commences research collaboration with Takeda |
1 |
https://app.sharelinktechnologies.com/announcement/asx/16b93d8dfab48afa2dbf48746fc20e40 |
|
| 2017-07-27 08:31:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/12d65a0e35ceb04c96fb5d6ef88c7f07 |
Commitments Test Entity - Fourth Quarter Report
|
| 2017-08-31 16:45:00 |
Appendix 4E and Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/38ab6eeaf0c13689e560046514203319 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2017-08-31 16:46:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c600e00f03443ef08608e5b57824484 |
|
| 2017-09-01 08:41:00 |
Form 20-F |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5a1dbdef95c120e299261b93cb8c76f5 |
|
| 2017-09-06 14:20:00 |
Annual Report filed on Form 20-F with SEC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5af6178f34c8500494662098902b12fc |
|
| 2017-09-25 17:59:00 |
Change of Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/80be8b6e6bea174e093407629e5cefcc |
Details of Company Address
|
| 2017-10-11 09:11:00 |
Form F-3 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7f19d140d789efd6d6bc5a9f1eaac000 |
|
| 2017-10-13 17:03:00 |
Notice of Meeting/ Proxy Form |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6d853fbbef66afac8e24074f8a65c4fe |
Notice of Annual General Meeting
|
| 2017-10-30 12:05:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f7df1b43dcd38d406bd62fb6e072348d |
Commitments Test Entity - First Quarter Report
|
| 2017-11-09 09:10:00 |
Prospectus Supplement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b3034e19c249c17d53b74b18a0961775 |
|
| 2017-11-09 09:13:00 |
Form 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5ace9121eef0058e28eb5fc6bcdd5204 |
|
| 2017-11-10 14:19:00 |
Prana AGM Investor Conference Call |
0 |
https://app.sharelinktechnologies.com/announcement/asx/42529569d25e49777556cb5db0e89a40 |
Notice of Meeting - Other
|
| 2017-11-17 09:02:00 |
AGM 2017 Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/489994ef8b80931dfb96c91790128314 |
Chairman's Address to Shareholders
|
| 2017-11-17 10:27:00 |
2017 AGM Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0b92c2a987cc5a6f4fa8065a180c1aea |
|
| 2017-12-19 09:12:00 |
Prana receives $3 million R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/06fd705d37a554c6d6f3a4406f178d2c |
|
| 2017-12-19 09:17:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e6775adeb9c1252ac408eaad0a0a9f2b |
|
| 2017-12-22 14:35:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9692aa5c960ba14af3f435aa3484b2d7 |
Change of Director's Interest Notice
|
| 2017-12-22 14:36:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/461377dbda535f432fd496b9baec68b3 |
Change of Director's Interest Notice
|
| 2017-12-22 14:37:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f85dba7a2c6e05786d5fbcfe453de28a |
Change of Director's Interest Notice
|
| 2017-12-22 14:37:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b0f4408231ec8701f995ed04467da8e2 |
Change of Director's Interest Notice
|
| 2017-12-22 14:37:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bc0de4b8ef0dd7592e227c016592b8ea |
Change of Director's Interest Notice
|
| 2018-01-08 17:37:00 |
Investor Presentation - Treatment of Neurological Disorders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2c38017e9f9926fcb8fc7cd63052aa1a |
|
| 2018-01-08 17:41:00 |
Dr. David Stamler presenting at Biotech Showcase |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3f20b9383eb18b5689fb5f1accb1a7b7 |
|
| 2018-01-18 09:33:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f617e914c2a9cad7bed8cf83eecab2d8 |
|
| 2018-01-31 08:58:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e02ce52ad5660ee300cd7c34b9a794cc |
Commitments Test Entity - Second Quarter Report
|
| 2018-02-28 18:16:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ab5aafa349d938f89e997d00421d48b3 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2018-02-28 18:17:00 |
Form 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/72d602a0c84b300494db3b550ac19b2a |
|
| 2018-03-06 16:03:00 |
PBT434 at the 6th International Multiple System Atrophy Conf |
1 |
https://app.sharelinktechnologies.com/announcement/asx/179dcf3440916d5b636e64c05a379920 |
|
| 2018-03-16 10:01:00 |
Prana to Present at the B. Riley FBR Symposium in China |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01f36ee07a988b06b63c45d29800b602 |
|
| 2018-04-27 16:16:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d0221b860062a5916f8f9536aa879d5f |
Commitments Test Entity - Third Quarter Report
|
| 2018-06-14 09:38:00 |
Prana to commence Phase 1 clinical trial of PBT434 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d823b6e142c63f55c45fc86513075aea |
|
| 2018-06-27 11:43:00 |
Investor Presentation - Treatment of Neurological Disorders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9516cf7befbb0238e4ad2d89b4520e31 |
|
| 2018-06-27 12:04:00 |
Investor Presentation (amended) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5b567fe5908bbde15e302fedc56cfe74 |
|
| 2018-07-04 09:33:00 |
First Volunteers Dosed in Phase I Clinical Trial of PBT434 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4757db3e9999a217c6d37ecd43b74d75 |
|
| 2018-07-09 09:25:00 |
Prana to present PBT434 data at International Congress |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c3aa52fded4d0f02dff23e1d3e435110 |
|
| 2018-07-13 09:20:00 |
Appendix 3B and 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/338045fdb1839a682a9bf976161a55df |
|
| 2018-07-31 09:40:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/72aa9ccc17f4ea7f6c787692fa8222ba |
Commitments Test Entity - Fourth Quarter Report
|
| 2018-08-31 17:03:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0fb0c2e3756cc3bc78071aa3bbd545e2 |
|
| 2018-08-31 17:12:00 |
Annual Report to shareholders |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b3c2c43a16c43510596a28f26fa1e0be |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2018-08-31 17:33:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d14b7585c3ab8768cbc141773f05bec6 |
Full Year Directors' Statement
|
| 2018-09-03 10:05:00 |
Form 20-F |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1d38bdd3772e871b167f7b9923b7d73f |
|
| 2018-09-03 11:26:00 |
Annual report 2018 on Form 20-F & XBRL data filed with SEC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4af10832cf572fb4e1af70bb47a26c27 |
|
| 2018-10-05 10:25:00 |
New data show potential for PBT434 to treat MSA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dda5513e9fe54c182e720fa925c98618 |
|
| 2018-10-17 09:04:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7a40da4c463a49fb40f466bdee28bfc8 |
Notice of Annual General Meeting
|
| 2018-10-30 10:40:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/080e27488d35fd56a5b5afc0f630535d |
Commitments Test Entity - First Quarter Report
|
| 2018-11-12 09:53:00 |
Prana AGM Investor Conference Call |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c0863e085dfdd4170511d14b407cdfbc |
Company Administration - Other
|
| 2018-11-16 09:02:00 |
2018 AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/26514bf50b467d31b3edfc0138ba4973 |
Chairman's Address to Shareholders
|
| 2018-11-16 11:38:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f64e73be755b8f5a2a02458e83837244 |
|
| 2018-11-16 15:53:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9c27065bc6a947cc8a98f8c2d583ad2b |
|
| 2018-11-16 16:00:00 |
Change of Director's Interest Notice - IS |
0 |
https://app.sharelinktechnologies.com/announcement/asx/91b63699ffc61005f797c0c29c5aa638 |
Change of Director's Interest Notice
|
| 2018-12-05 08:32:00 |
Form S-8 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e3861f0faa6fea1feba5dfb3328a3039 |
Company Administration - Other
|
| 2018-12-24 08:48:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/aa9768202af2904df557c300c6a3103d |
|
| 2018-12-28 09:01:00 |
Life Bioscience LLC leads strategic investment upto A$44.5M |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f43b01abb3e857bb0a6f8e65a342708c |
Security holder details - Other
Director Appointment/Resignation
|
| 2019-01-07 09:51:00 |
Appendix 3B & Section 708A notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48a966e9ac8beda298079a12bcaed1b6 |
|
| 2019-01-07 11:07:00 |
Prana Presents at Biotech Showcase |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9fad44867e30a8e6a2963da5ad70436c |
|
| 2019-01-07 11:11:00 |
Investor presentation - Biotech Showcase |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b8372773b4af61f6eaf83cfcb0580c3c |
|
| 2019-01-07 17:24:00 |
Becoming a substantial holder from MS |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f45d1b3d079db7c68c7eda41c211c6af |
Becoming a substantial holder
|
| 2019-01-07 18:29:00 |
Becoming a substantial holder from MUFG |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6a385e0bc6f3e379077977df01154211 |
Becoming a substantial holder
|
| 2019-01-09 13:03:00 |
Ceasing to be a substantial holder from MS |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5a1ba215fe7f3f44abf4629a4679eb51 |
Ceasing to be a substantial holder
|
| 2019-01-09 16:00:00 |
Ceasing to be a substantial holder from MUFG |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4a83fa4643d9736c321213a7bb160f2a |
Ceasing to be a substantial holder
|
| 2019-01-31 09:17:00 |
Orphan Designation for PBT434 for treatment of MSA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/06ff4a697fd0c72eae30f799f649c1d9 |
|
| 2019-01-31 16:19:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1c4dbeab98dda3ed2ff6cc7a8faec7f8 |
Commitments Test Entity - Second Quarter Report
|
| 2019-02-05 15:11:00 |
Appendix 3B & Cleansing notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/420bf68a4f9b5a9ccac7e57694a478c3 |
|
| 2019-02-28 16:50:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ed690afed38666b625b76e129fc87047 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2019-03-01 08:55:00 |
Form 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8cbee0ccfae010a47276f6c892d16d28 |
|
| 2019-03-06 09:46:00 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c1bc30657c9d8d90820886de62218925 |
Notice of General Meeting
|
| 2019-03-18 11:24:00 |
Prana receives A$3.3 million R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1a5f8b21dd26799556d423617adf7f83 |
|
| 2019-03-21 13:56:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/15a4f211cf30689efad81a42e24f8170 |
|
| 2019-03-27 15:32:00 |
Prana Biotechnology EGM and Conference Call Facility |
0 |
https://app.sharelinktechnologies.com/announcement/asx/51106da1727e0639faf8232c7cb134e6 |
|
| 2019-04-05 12:35:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/680563e0c5f7a273e2285fb95f382866 |
|
| 2019-04-08 18:10:00 |
Completion of investment by Life Biosciences & capital raise |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fc2643fdc1c87c361ea3f569d3f7ff8c |
|
| 2019-04-08 18:17:00 |
Change of Company Name |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3b4618fa1772c9f4cf1308a20ebd7a62 |
|
| 2019-04-10 11:15:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bd028d28173539fc426215142998b4be |
Becoming a substantial holder
|
| 2019-04-10 14:07:00 |
Alterity Therapeutics Launches to Asian Investors |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7bc8e25a2e4ab9b6bf1dc7bf562a7aff |
|
| 2019-04-10 14:25:00 |
Investor Presentation - April 2019 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/06ef83cd72a767e62439105612db97ab |
|
| 2019-04-11 09:07:00 |
Final Director's Interest Notice - IS |
0 |
https://app.sharelinktechnologies.com/announcement/asx/34ad009a15a1fd7859b4dc552fb93bef |
Final Director's Interest Notice
|
| 2019-04-11 09:07:00 |
Becoming a substantial holder - Alterity |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8ed184bc34d04abedec95d7da49b3f3f |
Becoming a substantial holder
|
| 2019-04-11 09:08:00 |
Initial Director's Interest Notice - TE |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b938dc42e92d2cc3c83ec7f4d729aa01 |
Initial Director's Interest Notice
|
| 2019-04-11 09:08:00 |
Final Director's Interest Notice - GM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a1808f66dbda265dae5d650f7522a3e8 |
Final Director's Interest Notice
|
| 2019-04-11 09:09:00 |
Initial Director's Interest Notice - DS |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2ee2cdb6c56579528ca83806d40e49c2 |
Initial Director's Interest Notice
|
| 2019-04-17 09:02:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d964847e5aa891936e62cf741cc858fb |
Commitments Test Entity - Third Quarter Report
|
| 2019-05-03 14:27:00 |
ATH presents at the American Academy of Neurology |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4dbc02b7e5fef5f76183db0208291f92 |
Company Administration - Other
|
| 2019-05-06 09:47:00 |
Alterity presents initial Phase 1 clinical trial data at AAN |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f9b73f39be5f73641dcb595feaf68c08 |
|
| 2019-05-08 08:25:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/50a6f2477a89afd99c21ce10e8161325 |
Becoming a substantial holder
|
| 2019-05-08 09:31:00 |
Form 603 Notice lodged by Bank of New York Mellon |
0 |
https://app.sharelinktechnologies.com/announcement/asx/22b664e1aadb44907fb2768b349ad00e |
Security holder details - Other
|
| 2019-05-13 10:40:00 |
Alterity Therapeutics commences US investor meetings |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5b525e6cea80132f6d5bfc26a8381b65 |
|
| 2019-05-14 09:35:00 |
FORM F-3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9b7357af259bb60fbc167a0976efca7b |
|
| 2019-05-20 09:46:00 |
Upcoming Release of Shares from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/07856682872f7d7042705289e2893a31 |
|
| 2019-05-23 10:10:00 |
Prospectus filed pursuant to SEC Rule 424(b)(3) |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4453c2fccde2c39acd08e1337bf0ce97 |
|
| 2019-06-04 09:19:00 |
Alterity Therapeutics presents to Finance News Network |
0 |
https://app.sharelinktechnologies.com/announcement/asx/84beab7365c5d7c3e7d59cf2cbf25366 |
|
| 2019-06-04 11:39:00 |
Ceasing to be a substantial holder - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e5fa5595b4b05e42ae11b9fc8d187a64 |
Ceasing to be a substantial holder
|
| 2019-07-29 13:42:00 |
Successful Completion of Phase 1 Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/eab63783f111ea96ef3a5d846019eeeb |
|
| 2019-07-31 15:22:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f26563894fc9ad750d34757d74b311db |
Commitments Test Entity - Fourth Quarter Report
|
| 2019-08-01 16:11:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a6c416c0aee42b2634d78bbd35315285 |
|
| 2019-08-05 10:33:00 |
Upcoming Release of Shares from Voluntary Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1ac12e5147bac4ac2f4d911e13ac54f0 |
|
| 2019-08-20 12:29:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d2ccc51eaeb71ac6baf9aceda5b1cc0a |
Change in substantial holding
|
| 2019-08-30 17:25:00 |
Appendix 4E & Annual Report 2019 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/55b84371903ee2bd791b6b1c88693120 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2019-08-30 17:28:00 |
Appendix 4G & Corporate governance statement 2019 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/897a4fabb39c90bdd4d5756e203ba27c |
|
| 2019-09-02 09:38:00 |
Form 20-F |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aeef55012cddb5a521b7493a55996f09 |
|
| 2019-09-02 14:02:00 |
Annual Report 2019 and XBRL data filed with the SEC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d8d8e925515fefa12a4d73a555822839 |
|
| 2019-09-09 11:32:00 |
Alterity to Present at the Janney Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a8302d42b62a3d903cc227d3ddc3da2e |
Company Administration - Other
|
| 2019-09-24 18:29:00 |
ATH presents PBT434 clinical data at the 2019 MDS Congress |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fbf0b41599951fb0a6da9aa8f93fd907 |
Company Administration - Other
|
| 2019-10-25 16:22:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a12a264a4848d49f8d5dbe864fbde6fc |
Notice of Annual General Meeting
|
| 2019-10-30 15:45:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3ed3dcf228eef9146eb4ffc799ad26ed |
Commitments Test Entity - First Quarter Report
|
| 2019-11-18 11:05:00 |
Lead drug candidate receives positive opinion from EMA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5b0b12848fa7c914a13a3c64edfe0126 |
|
| 2019-11-20 11:25:00 |
Alterity AGM Investor Conference Call |
0 |
https://app.sharelinktechnologies.com/announcement/asx/92d56ef7facca0807aacfdc770384fda |
|
| 2019-11-21 17:35:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/afce62ea937c41acae310494f5e629b1 |
|
| 2019-11-26 09:35:00 |
Chairman's Address to Shareholders |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a90d4ea579d3160e8d381d5f3f35e38c |
Chairman's Address to Shareholders
|
| 2019-11-26 09:38:00 |
AGM Presentation 2019 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a3c5182937cd9fb56f4191bfdcfc60bd |
Chairman's Address to Shareholders
|
| 2019-11-26 11:24:00 |
AGM Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/33d1199afdf645c909f0383254730bb3 |
|
| 2019-12-11 09:55:00 |
Upcoming Release of warrants from Voluntary Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a54f63487083254d1810455cbf2a8370 |
|
| 2020-01-14 12:23:00 |
European Orphan Designation granted for PBT434 for MSA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f09f7ae147dba5bc6828816be77f386e |
|
| 2020-01-15 09:22:00 |
Alterity receives a $4.8 million R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/14bee80e760107305ca9a88b96038006 |
|
| 2020-01-17 14:03:00 |
Appendix 3B an 708A notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3bfb0ff79f8160d1c2168db6627b38a2 |
|
| 2020-01-31 15:11:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/935cd4e1028fb0dbd76f6a666c479c1b |
Commitments Test Entity - Second Quarter Report
|
| 2020-02-07 14:40:00 |
NASDAQ Non-Compliance Notice Received |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d5e82f4a88e4adf8347f8a94ac4cdacd |
|
| 2020-02-27 17:36:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4645a75136e428dab12e66f01a31e5b3 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2020-02-28 08:36:00 |
Form 6K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d4380ff4ca5dac7f3df211f7720bbbb4 |
|
| 2020-03-26 08:45:00 |
Proposed issue of Securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0143fc31ac846b048ade20bae71ba09b |
|
| 2020-03-27 08:55:00 |
Appendix 2A and Section 708A(5) Cleansing |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b8545c4b7b7d5deb41e1ae543c7d276f |
Appendix 2A (Application for Quotation of Securities
|
| 2020-04-22 09:59:00 |
NASDAQ Temporary Relief |
1 |
https://app.sharelinktechnologies.com/announcement/asx/59941632f0707a6295860abb9ec6824b |
Company Administration - Other
|
| 2020-04-30 14:42:00 |
Appendix 4C and Quarterly Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/72193d8b558456ea4c4d039493315a00 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
| 2020-05-21 08:21:00 |
Presentation on ATH434 to American Academy of Neurology |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e71405e00faa572d98b3f02381c10a0a |
|
| 2020-05-22 18:42:00 |
Proposed issue of Securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/11e1fdfadb5f352c06cdeb0fac2fe8ba |
|
| 2020-05-25 16:50:00 |
Appendix 2A and Section 708A(5) Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a3dae0b83bc28f7821afa2e781df17a5 |
Appendix 2A (Application for Quotation of Securities
|
| 2020-05-27 08:19:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0de6beb5a34ae49e2a5917f058c98e02 |
Change in substantial holding
|
| 2020-05-27 09:42:00 |
Change in substantial holding (BMYMC) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c168d9a69e147c3fd250e4d0a8babcb |
Change in substantial holding
|
| 2020-05-28 08:18:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a94ebb5da50b1086b8b2cbf41c35aedd |
Change in substantial holding
|
| 2020-06-09 08:13:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0cde944b089ee38c010407616f4ae766 |
Change in substantial holding
|
| 2020-06-30 10:34:00 |
Meeting with US FDA provides development path for ATH434 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7a772d4f1dac77b781f0ee0290368844 |
|
| 2020-07-01 11:21:00 |
Pause in Trading |
1 |
https://app.sharelinktechnologies.com/announcement/asx/53b5cba1ce95fd623215b5aafbfaec9f |
|
| 2020-07-01 15:03:00 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/17e3c39dc6bbd36445285ddd83b891a5 |
|
| 2020-07-01 16:41:00 |
Proposed issue of Securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/51d7826f6458e72edfa5c9ff20224e1d |
|
| 2020-07-02 12:54:00 |
Appendix 2A and Section 708A(5) Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9c9bf8e0cbfd5bc0cb2e234f2b43f458 |
Appendix 2A (Application for Quotation of Securities
|
| 2020-07-06 08:17:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9c9e9a8d9c4014d20d8fea9b5aa6f5be |
Change in substantial holding
|
| 2020-07-07 09:13:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/068f004bcb219b125e15af712f84aed5 |
Change in substantial holding
|
| 2020-07-08 08:26:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0c79a853a7d0a99a43b73ac2eaf7274b |
Change in substantial holding
|
| 2020-07-09 08:19:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/369162cfac33557db00817d456ccb7d4 |
Change in substantial holding
|
| 2020-07-13 08:16:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d245300e37775692f514ea8b326f72b6 |
Change in substantial holding
|
| 2020-07-15 08:17:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5adb6d3c9e8d1c6615075ecd0698d7e6 |
Change in substantial holding
|
| 2020-07-30 10:35:00 |
Appendix 4C and Quarterly Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3c13a7b5c2d45cbaca97808d1dd36e3b |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
| 2020-08-03 17:36:00 |
Notice of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d58b56972a81722a4be053d34dff29ba |
Notice of General Meeting
|
| 2020-08-04 09:49:00 |
New data independently confirms safety profile of ATH434 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c4019594c352d33c216b8de0bb1c75a5 |
|
| 2020-08-17 08:12:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c727147b20f1edad349c8267cbc8d308 |
Change in substantial holding
|
| 2020-08-31 09:14:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/11ae6a4891845aca22e872f9437ce227 |
|
| 2020-09-03 18:44:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0a5afb794e4a3d7c3306e6691d12c9cc |
|
| 2020-09-09 12:08:00 |
Company update on Annual Report 2020 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8a9b8a7ab509b1fbbac8a96bf252c740 |
|
| 2020-09-09 12:11:00 |
Annual Report 2020 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/32955540afef341389857f446198898a |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2020-09-09 12:12:00 |
Appendix 4G and 2020 Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5587d41a535be738b33347b0d95e9dcd |
|
| 2020-09-16 09:05:00 |
ATH filed Form 20-F and XBRL data with SEC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/023246cc54d57f002926867d7747233f |
Company Administration - Other
|
| 2020-09-16 09:06:00 |
Form 20-F |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2166eb7d98d13b628c48a8e947b51f95 |
|
| 2020-09-18 18:31:00 |
Appendix 3G Notice of issue of ESOP Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9b1cf50598f7918efd2f55bc2363d3a1 |
|
| 2020-09-21 17:34:00 |
Change of Director's Interest Notice x 5 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2c6b4c1f1bc49cfeedcbcdcb117ea2db |
Change of Director's Interest Notice
|
| 2020-09-24 09:32:00 |
Form S-8 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/206c090279205c4ff5a3cf7810b1f4df |
|
| 2020-10-06 12:08:00 |
Form F-3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/77cc33453cdfd4fa26856d9b66bfcc31 |
|
| 2020-10-12 09:35:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/30148530da184640926a3a424aaad845 |
|
| 2020-10-16 09:28:00 |
Alterity raises $35M in placement to institutional investors |
1 |
https://app.sharelinktechnologies.com/announcement/asx/deb8526e2f99ef39b01e7d13f246399d |
|
| 2020-10-16 09:29:00 |
Proposed issue of Securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4a9569f793fdb5524e8aab0e16ff828f |
|
| 2020-10-16 09:29:00 |
Proposed issue of Securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aa46c8a17596a870dc27b827c1c34d4a |
|
| 2020-10-20 10:59:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/723560286ff20ea3e0242ded8febf826 |
Notice of Annual General Meeting
|
| 2020-10-23 11:44:00 |
Appendix 2A and Section 708A(5) Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a6ceb1da7115e0c570a3341ce6cfd944 |
Appendix 2A (Application for Quotation of Securities
|
| 2020-10-23 11:48:00 |
Alterity completes Placement Tranche 1 raising $10M |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cd2cc8993f6dc7366ba6965c2ddfbd47 |
|
| 2020-10-26 11:45:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/73c829137326525b6dd5b6e91bef2fa8 |
Change in substantial holding
|
| 2020-10-27 08:16:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d050f6e738b47562e75022a81a872c13 |
Change in substantial holding
|
| 2020-10-27 09:21:00 |
MSA patients enrolled in bioMUSE Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0c504900058ea151f8e9010c422035bb |
|
| 2020-10-30 09:34:00 |
Appendix 4C and Quarterly Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c00f79ad287fc2f6f007614c58062839 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
| 2020-11-13 15:04:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/90eeb2f4c36500a37c5ac9b996bac7a3 |
Becoming a substantial holder
|
| 2020-11-16 09:37:00 |
US patent for next generation neurodegenerative diseases |
1 |
https://app.sharelinktechnologies.com/announcement/asx/da94d5b2cc6119ebc35b02ffe3dddf0c |
|
| 2020-11-16 14:20:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/975bbdad8143f35bf5a62ee9ae81786c |
Ceasing to be a substantial holder
|
| 2020-11-16 15:35:00 |
Form F-3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/410d224dcc5fa6a6b22cac0b07494534 |
|
| 2020-11-16 18:00:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/10637a0e7b191d59f2f934da1bd848af |
Ceasing to be a substantial holder
|
| 2020-11-18 09:20:00 |
Chairman's Address 2020 Annual General Meeting |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8cace7659c00534a5d7075604f05e2e2 |
Chairman's Address to Shareholders
|
| 2020-11-18 09:23:00 |
ATH Annual General Meeting Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4b4b075542871fdb5587fa901b69d232 |
Chairman's Address to Shareholders
|
| 2020-11-18 13:28:00 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2cf4533b0d8e662a0d5be02ba436c30e |
|
| 2020-11-18 13:31:00 |
ATH Constitution (amended) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d23cfa7e89a44a522279629c331240aa |
|
| 2020-11-19 08:25:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/71ef7d2a8e9acd5bea77ace022c1d5d4 |
Change in substantial holding
|
| 2020-11-23 08:23:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/248f91b28679f65a48dd140d71f56431 |
Change in substantial holding
|
| 2020-11-24 08:23:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/daafcdce6e165d92d502e643fdd23ec9 |
Change in substantial holding
|
| 2020-11-24 13:33:00 |
Appendix 2A and Section 708A(5) Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b09a49a7b7946e58e9c7c082794e3fe9 |
Appendix 2A (Application for Quotation of Securities
|
| 2020-11-24 13:34:00 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7633a55d4706588662a98006b5c838f8 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2020-11-24 14:42:00 |
Prospectus filed pursuant to SEC Rule 424(b)(3) |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b5062d69cc3249f530444cd40758c878 |
|
| 2020-11-25 08:21:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8f500068f04ac1b699e7364b44f188a0 |
Change in substantial holding
|
| 2020-11-26 08:38:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/882082290180bf6d2466b6cf7bd7f601 |
Change in substantial holding
|
| 2020-11-26 16:22:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cd97c99ddbc250700d4a0b9b4bf8d371 |
Becoming a substantial holder
|
| 2020-12-01 08:23:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/88e00528666bed0881768e1422c5eca5 |
Change in substantial holding
|
| 2020-12-01 10:42:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/635cc81be6f4f9232e5623a76972deb2 |
Change in substantial holding
|
| 2020-12-02 09:15:00 |
Alterity presents at Finance News Network |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8bcceefc5a7e4e8788bbe840b4ef93ad |
Company Administration - Other
|
| 2020-12-03 09:48:00 |
Form S-8 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2a683f0cf00d2773074202713903fd5a |
|
| 2020-12-04 08:20:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6342fc1f62d0a4981b62c3f8908c6134 |
Change in substantial holding
|
| 2020-12-10 08:22:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d31ca9edaab2f7667e7a7436686d5fd7 |
Change in substantial holding
|
| 2020-12-17 10:07:00 |
Prospectus Supplement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0794fd5ade2d01316d698b4e2c40692f |
|
| 2020-12-17 10:09:00 |
Form 6-K |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dc8af3b971cbad2e057aa9ac72c73f09 |
Company Administration - Other
|
| 2020-12-18 08:20:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b27f2089350637494e049259a546627a |
Change in substantial holding
|
| 2020-12-21 18:31:00 |
New commercial opportunity for PBT2 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0a5f8757d430e5de09bf67726cb9bcdf |
|
| 2020-12-24 08:29:00 |
Form F-3 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d86cab2caa5a801d3346cd8c96259d49 |
|
| 2020-12-29 08:36:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dface4dc699f11904c669e4ba9199623 |
Change in substantial holding
|
| 2021-01-07 09:39:00 |
Dr David Stamler Appointed CEO |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bb93c712e9ccf6ce5d25a58477c9baee |
Company Administration - Other
|
| 2021-01-11 12:03:00 |
Alterity participates in JP Morgan healthcare conference |
1 |
https://app.sharelinktechnologies.com/announcement/asx/39d67fd692683e2a00ea64b2431992b3 |
|
| 2021-01-14 16:40:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eae46ff22388574d53ce9170afee375d |
Change in substantial holding
|
| 2021-01-28 16:32:00 |
Appendix 4C and Quarterly Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cae00ff6eeff4055f12d98769acf5b35 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
| 2021-02-09 09:19:00 |
Michael J Fox grant for Parkinson's research on ATH434 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/31e4103a8bb5bb38b77ec9571a44d557 |
|
| 2021-02-10 16:38:00 |
Proposed issue of Securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2588963a6c82330fb1fb220bc53998d4 |
|
| 2021-02-11 08:21:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4a63bdfa9e5ce4848cf3ff6e9645e2d8 |
Change in substantial holding
|
| 2021-02-11 12:20:00 |
Appendix 2A and Section 708A(5) Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/826df135d6105c48b7b4296b63357af7 |
Appendix 2A (Application for Quotation of Securities
|
| 2021-02-12 16:35:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3b034f2992e736402351992de9ca86a5 |
Change in substantial holding
|
| 2021-02-15 08:15:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/28cc5f84a9f776183919a25c8f7b9c41 |
Change in substantial holding
|
| 2021-02-15 16:38:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4c1e5d95bc524a77ff77a5841b637fe9 |
Change in substantial holding
|
| 2021-02-16 08:13:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/81b8e294a939bfa95520647ad87f1508 |
Change in substantial holding
|
| 2021-02-19 10:44:00 |
Alterity Half Year Results and Investor Webcast Notification |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5a575e125a09553334bf71c9838f878c |
|
| 2021-02-22 08:17:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c96c6ff224a46f451f33599670b896ef |
Change in substantial holding
|
| 2021-02-25 12:54:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/548ae9d04eff838b07a0467e0a1f227e |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2021-02-26 14:20:00 |
Alterity to present at 7th International Congress of MSA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a534d2a483f1b2d7ed3e855a700d5e9d |
Company Administration - Other
|
| 2021-02-26 16:19:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c02505847ed88c4e3138e6845667dcf0 |
Change in substantial holding
|
| 2021-03-10 11:29:00 |
Alterity to present at Global Life Science Conference |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c6f7e5aebc2a84b3de13cb1950e1c417 |
Company Administration - Other
|
| 2021-03-15 16:40:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cfb40039810c537242b75864743a12c7 |
Change in substantial holding
|
| 2021-04-20 15:48:00 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8a6b744e425c60feceafe3622f3be05d |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2021-04-21 13:07:00 |
ATH434 protects brain cells and improves motor function |
1 |
https://app.sharelinktechnologies.com/announcement/asx/86bb1457393db04f92d0ae88b5ce7129 |
|
| 2021-04-23 16:53:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2aa12f77223a5869182b9b9377f75b2a |
Ceasing to be a substantial holder
|
| 2021-04-28 08:20:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/30140053e11dbb60e3245155326fcc9d |
Change in substantial holding
|
| 2021-04-29 09:15:00 |
Appendix 4C and Quarterly Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a83359f13d8253cc659b8636431f2da7 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
| 2021-06-16 08:46:00 |
Alterity to present at MST Access Investor Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c4e72bb48415561a25fd2e0a54e066c6 |
|
| 2021-06-17 09:20:00 |
Investor Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/16e0258a7ced058b3852cd5c0e1d0a5d |
|
| 2021-06-23 10:56:00 |
EU Regulatory Guidance for ATH434 Phase 2 Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/27c26b4f080e485d648023c8bb4eee91 |
|
| 2021-06-30 08:20:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0afe98eef4ea5934488255bb1e9ac78a |
Change in substantial holding
|
| 2021-07-01 12:04:00 |
New US patent targeting major neurodegenerative diseases |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6a86fdd257107320afe47692be35d282 |
|
| 2021-07-02 16:14:00 |
Proposed issue of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a7fa6686e01250cb2807cc8fd3e8a6e8 |
|
| 2021-07-05 09:54:00 |
Application for quotation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/75e4d72c3ed5b93c02125510cfd3640c |
Appendix 2A (Application for Quotation of Securities
|
| 2021-07-05 09:57:00 |
Notice under section 708A(5) of the Corporations Act |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9045e16b62f6d2d30431aba984c01a35 |
|
| 2021-07-06 08:18:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8fce0d0153521e940ece529c27bcd590 |
Change in substantial holding
|
| 2021-07-08 08:21:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/da51c2cdcf291bf0d63a757658ef9b91 |
Change in substantial holding
|
| 2021-07-09 08:20:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1644c8cc40427a1a9772764227ca3642 |
Change in substantial holding
|
| 2021-07-09 10:35:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/96d41a8d251e6596f1036fb0e8d99059 |
Change in substantial holding
|
| 2021-07-13 08:19:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a8d6f3f0b3ad3933c3b6816fd353d179 |
Change in substantial holding
|
| 2021-07-15 10:27:00 |
New Publication Demonstrates ATH434 is Neuroprotective |
1 |
https://app.sharelinktechnologies.com/announcement/asx/97a35dc3cef18c7ad47141587ca0a26a |
|
| 2021-07-30 10:57:00 |
Appendix 4C and Quarterly Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3bf70935b25d48fe0ef502e9cff02a92 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
| 2021-08-04 14:42:00 |
New US Patent Expands Neurodegeneration Treatment Portfolio |
1 |
https://app.sharelinktechnologies.com/announcement/asx/53d98777c6ead2e30f715a6de8b197e5 |
|
| 2021-08-12 08:15:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c68d5e7a34014d8c50f67d9d7ab83ca6 |
Change in substantial holding
|
| 2021-09-01 08:12:00 |
Appendix 4E & Annual Report 2021 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1c9db7fcdb252065c9a2636e3b69cfad |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2021-09-01 08:12:00 |
Appendix 4G and Corporate Governance Statement 2021 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/46311647309f9cab17a62c511705f132 |
|
| 2021-09-01 08:17:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a1e76e39527149f548c4c42d8990b99b |
Change in substantial holding
|
| 2021-09-03 09:29:00 |
ATH filed Form 20-F and XBRL data with SEC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/51b029250929a871d60cfad89c30a925 |
Company Administration - Other
|
| 2021-09-03 10:17:00 |
Form 20-F |
1 |
https://app.sharelinktechnologies.com/announcement/asx/59b52765f14f4865f5b3d74b114b0ce1 |
|
| 2021-09-20 16:23:00 |
Presentation of New Biomarker Data at Scientific Congress |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a872944fed082efae07e52a0b7599874 |
|
| 2021-10-11 16:46:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0b5f3befe5fcdba056004d772d75e5bb |
Notice of Annual General Meeting
|
| 2021-10-19 09:11:00 |
Expanded ATH434 Phase 2 Clinical Development Program |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f35dd68fec9ef9b284d73edcbb5a198e |
|
| 2021-10-29 10:51:00 |
Appendix 4C and Quarterly Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/14435f81d463f83b610b82e767726425 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
| 2021-11-03 08:16:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/855ed31496c0e3ae9af8a7493d689c80 |
Change in substantial holding
|
| 2021-11-04 13:23:00 |
New Data Advance ATH434 as Neurodegeneration treatment |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7a3daae274a715d29df3cfb017070ce3 |
|
| 2021-11-09 12:49:00 |
Alterity presents at American Autonomic Society Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9dda708a240d96935b52ac0f62f9c260 |
|
| 2021-11-12 08:50:00 |
Chairman's Address 2021 Annual General Meeting |
1 |
https://app.sharelinktechnologies.com/announcement/asx/647e37345adb485539df0d5b6628b7e6 |
Chairman's Address to Shareholders
|
| 2021-11-12 08:53:00 |
ATH Annual General Meeting Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b5a2b9a5dc197115b76d120cf78ef31a |
|
| 2021-11-12 11:42:00 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e82954ad1d52b51dca3946a9a2575e96 |
|
| 2021-11-22 11:14:00 |
Alterity to present at upcoming investor conferences |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c9b89ffb70d78ef1874cfe27c236b3c6 |
Company Administration - Other
|
| 2021-11-24 08:16:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9f8276248ae0ca3e35db8d2fca808268 |
Change in substantial holding
|
| 2021-12-06 08:21:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5cbaf1a3a6e395b2b44860125fb861f2 |
Change in substantial holding
|
| 2021-12-09 16:16:00 |
Notification regarding unquoted securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1715ffa4ed625bc267c7f367702055a1 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2021-12-14 09:41:00 |
First Regulatory Authorization to Proceed with Phase 2 Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5619677be5fd284b7084dedc4f777e63 |
|
| 2021-12-15 13:42:00 |
Notification of cessation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/abd68c5dfac5d7af4d35096f2841a255 |
Appendix 3H (Notification of cessation of securities)
|
| 2021-12-22 08:25:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/66b699c6be5ed5a4ca84ed22a15e65c4 |
Change in substantial holding
|
| 2022-01-04 16:53:00 |
Alterity announces resignation of Non-Executive Directors |
0 |
https://app.sharelinktechnologies.com/announcement/asx/51301434670423140b47dadbc8131319 |
Director Appointment/Resignation
|
| 2022-01-05 10:10:00 |
Notification of cessation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01472b0e9089cd9342224d0c01817d01 |
Appendix 3H (Notification of cessation of securities)
|
| 2022-01-05 10:14:00 |
Final Director's Interest Notice x 2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bf78221ca9b82231c50b8fc7bfa42618 |
Final Director's Interest Notice
|
| 2022-01-05 10:33:00 |
Alterity to present at H.C. Wainwright Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c0c768b3ec0ab853d3e3e502a4c17506 |
Company Administration - Other
|
| 2022-01-06 10:15:00 |
New US Patent for Compounds to Treat Neurodegeneration |
1 |
https://app.sharelinktechnologies.com/announcement/asx/99806a147cf89b7e464be998b4bc77ad |
|
| 2022-01-07 08:21:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bd8e4242c6b97d692dd9a43ce692ce92 |
Change in substantial holding
|
| 2022-01-13 08:32:00 |
Response to ASX Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fab288e18fcd0ddfb444248399072945 |
|
| 2022-01-24 08:02:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e9859f5241bb0f665529a740f3411af5 |
Change in substantial holding
|
| 2022-01-27 14:47:00 |
Appendix 4C and Quarterly Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6bae61223c71054172eb5fb097f8bae6 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
| 2022-01-28 13:47:00 |
New publication shows ATH434 rescues neurons in MSA model |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d67585cfe54b391c4912b37ec59b21d5 |
|
| 2022-02-28 14:23:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6b3fe17fbfebc4edf2374a5f955260ea |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2022-03-01 09:59:00 |
NASDAQ Non-Compliance Notice Received |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b42a66177dc7b0ffe37702af79622dcf |
Company Administration - Other
|
| 2022-03-07 10:27:00 |
Alterity to Present at the 34th Annual Roth Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b04065ccae25f003a5389ffbb149f9b0 |
Company Administration - Other
|
| 2022-03-07 10:37:00 |
Investor Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8548f887d7cf92cdbbf5f534dd877c9e |
|
| 2022-03-15 10:16:00 |
Alterity to participate in Sachs Neuroscience Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f69b12baa8099de6de1cd7d50bc091c3 |
Company Administration - Other
|
| 2022-03-17 08:21:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/47a206d52ef86ba19da08837f734c6ea |
Change in substantial holding
|
| 2022-03-22 16:49:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/682f1c0da136896ea21bfbe24b0670e1 |
Change in substantial holding
|
| 2022-04-07 10:41:00 |
Presentation of bioMUSE Data at the AAN Annual Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2864a0bfe8fe6ba33683670321186537 |
|
| 2022-04-27 12:06:00 |
UK Regulatory Authorisation to Proceed with Phase 2 Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/780afd73736087b3879b4c7178e535ba |
|
| 2022-04-29 14:07:00 |
Appendix 4C and Quarterly Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/597d4ed203a96f5517576aaa70381c0e |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
| 2022-05-04 08:10:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e84f9b9705124a0b32a6394462f048bc |
Change in substantial holding
|
| 2022-05-26 12:35:00 |
Alterity to Participate in the Benchmark Company Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4b1e674d654aa1b9bba236e211fde1b1 |
|
| 2022-06-02 09:59:00 |
Alterity Launches ATH434 Phase 2 Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1c180ee5eb4c9187ec5d9f8a1a69fed2 |
|
| 2022-06-14 14:33:00 |
Alterity to present at GCFF Virtual Conference 2022 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/30874bc3d7580ea47e2bbdf5ea6c1b66 |
|
| 2022-06-20 09:04:00 |
Alterity to Present at Life Sciences Investor Forum |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fb90cc05630198d45bd70a403d3e18ad |
|
| 2022-06-23 09:16:00 |
Regulatory Approval to Proceed with Phase 2 Trial in Italy |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d661ed56e67b2489e299c1059c182c7a |
|
| 2022-06-27 10:03:00 |
Notification of cessation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b44d9cd00fa0a0799c1152959508905f |
Appendix 3H (Notification of cessation of securities)
|
| 2022-06-30 15:47:00 |
Alterity receives a $4.1 million R&D Tax Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e17e607e7070535a05c415750d72427c |
|
| 2022-07-06 09:50:00 |
First Patient dosed in ATH434 Phase 2 Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b3e6087448043d2b0508c23609831cd7 |
|
| 2022-07-20 14:11:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/237feeba83ae98c3dd5a0ec4cc3a264a |
Change in substantial holding
|
| 2022-07-22 12:19:00 |
Appendix 4C and Quarterly Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/235dcab01d42041f49e6aeabf60997eb |
Fourth Quarter Activities Report
Fourth Quarter Cashflow Report
|
| 2022-08-02 15:01:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3fb795325e66f9d8ae852edd5828a2e9 |
Change in substantial holding
|
| 2022-08-24 16:45:00 |
Extension to regain NASDAQ minimum bid price compliance |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b2584602cf667936b2d1b602397cbb96 |
Company Administration - Other
|
| 2022-08-25 09:50:00 |
ATH434 Phase 2 clinical launched in Europe |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5c6c93db649627884efef1d9b980410e |
|
| 2022-08-26 15:13:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/897678dee8a1ba81b158e9b857c536c5 |
Change in substantial holding
|
| 2022-08-31 18:16:00 |
Appendix 4E & Annual Report 2022 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8fd75e0ab4fc1778d56d5019d4f0e496 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2022-08-31 18:20:00 |
Appendix 4G and Corporate Governance Statement 2022 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/13b4133532e096c31edc1e8baa1ed081 |
|
| 2022-09-01 09:12:00 |
Alterity Form 20-F and XBRL data filed with SEC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bbc11110ed5dc34e6fb9ad45e3b65337 |
Company Administration - Other
|
| 2022-09-20 09:25:00 |
US FDA Approval for IND Application for ATH434 for MSA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1b0c10a59fc29f2596cb105a604baf1b |
|
| 2022-09-21 14:16:00 |
Proposed issue of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7ea8a0a90244e3145a97e89cdb8bf0f4 |
|
| 2022-09-23 12:06:00 |
Application for quotation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eeb0d92ef51056859a35b2307a40e86e |
Appendix 2A (Application for Quotation of Securities
|
| 2022-09-23 12:23:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6ed96ea4fca9087110246b57ee05dbd0 |
|
| 2022-09-26 10:48:00 |
Wearable Sensor Data from bioMUSE Natural History Study |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8b8fbf39299739eb3727618359790dd3 |
|
| 2022-09-28 08:12:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9fd94efe87bfce20514e79cf5a4ceb84 |
Change in substantial holding
|
| 2022-10-13 09:09:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/500bdd8e6e618a423256e1d7eac4cf97 |
Notice of Annual General Meeting
|
| 2022-10-13 13:03:00 |
ATH434 Clinical Trial launched in Australia |
1 |
https://app.sharelinktechnologies.com/announcement/asx/de6d08d8ba627a6742f76fbfb00f0a3c |
|
| 2022-10-26 08:26:00 |
Presentation of bioMUSE MRI data |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7d9be40c2b481ac1e6003ddc64013fcc |
|
| 2022-10-28 15:47:00 |
Appendix 4C and Quarterly Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/09e0b295f4610de8e317ae77f30a79d0 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
| 2022-11-01 17:34:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c97c773df98ceffae7ed7e314918eb13 |
Change in substantial holding
|
| 2022-11-04 08:17:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/14e1949a2cb5d72505fbf15889913e0b |
Change in substantial holding
|
| 2022-11-07 12:14:00 |
Presentation of bioMUSE urinary symptom profile data |
0 |
https://app.sharelinktechnologies.com/announcement/asx/61ea6483e6fe46e46879ccbeb0ad9ffa |
Company Administration - Other
|
| 2022-11-11 08:58:00 |
ATH Annual General Meeting Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/26f5bc74e070dbf4543baf2179cf3344 |
Chairman's Address to Shareholders
|
| 2022-11-11 09:34:00 |
Chairman's Address 2022 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/68a91677267aec716beb2c885707391e |
Chairman's Address to Shareholders
|
| 2022-11-11 11:50:00 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/75b81889c9212b523f061b998a59fd2a |
|
| 2022-11-16 09:14:00 |
ATH Constitution (amended) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/781c9682d65a7707fbec728796a51e54 |
|
| 2022-12-14 08:18:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0e9f274ea463bc73acc00cefbf07f7bd |
Change in substantial holding
|
| 2022-12-15 15:18:00 |
Notification of cessation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e48e3e5f3141c4861d4c34e009b4e197 |
Appendix 3H (Notification of cessation of securities)
|
| 2022-12-15 15:31:00 |
Change of Director's Interest Notice x 4 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/89f802632fd49ab795b67459888ff1dc |
Change of Director's Interest Notice
|
| 2022-12-29 11:56:00 |
New US patent for compounds to treat neurodegeneration |
1 |
https://app.sharelinktechnologies.com/announcement/asx/18d37d35b3a9df1803afbf172a1c5166 |
|
| 2023-01-03 10:07:00 |
Alterity to participate in Sachs Neuroscience Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bc08015125913459c12cfe5b9aa7bbc1 |
Company Administration - Other
|
| 2023-01-06 17:05:00 |
ADS ratio change |
0 |
https://app.sharelinktechnologies.com/announcement/asx/906f441857946a02dae6835d06490f19 |
|
| 2023-01-09 11:40:00 |
ATH434 clinical trial launched in the US |
1 |
https://app.sharelinktechnologies.com/announcement/asx/343096e2eb9a4ae1a22346e2be82acc9 |
|
| 2023-01-25 09:50:00 |
ATH434 Clinical Trial Launched in Italy |
1 |
https://app.sharelinktechnologies.com/announcement/asx/50de4327dd4a9a47130556e0df9f1dda |
|
| 2023-01-30 15:28:00 |
ATH434 Prevents Brain Cell loss in Parkinsons Animal Model |
0 |
https://app.sharelinktechnologies.com/announcement/asx/09f375a5693d6e535f03acdf4d850fb6 |
|
| 2023-01-31 09:25:00 |
Appendix 4C and Quarterly Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3331c07acbc446c83ef11dc44f51ec69 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
| 2023-02-01 18:29:00 |
Notification of cessation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e7112dd48e0644f72f2c23d2fa1b6f27 |
Appendix 3H (Notification of cessation of securities)
|
| 2023-02-15 08:03:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/50238984775b6d183be5c93e7c025a13 |
Change in substantial holding
|
| 2023-02-16 12:30:00 |
Regulatory approval for Phase II trial in France and Austria |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6a270bd356c6ffb37276d5cffba3dca5 |
|
| 2023-02-28 13:18:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cdb970d20db77cbaddf499ba66f637d8 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2023-03-08 09:19:00 |
First Patient Enrolled in Europe in Phase II Clinical trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4929b640800b89dbe66780aa1cbc6c84 |
|
| 2023-03-09 09:12:00 |
Investor Webinar Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aee86c55cc78c695bcdb44ec59fa6933 |
|
| 2023-03-14 10:42:00 |
US patent grant and license agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/985a7fa3736b055b893f4213b09c5f55 |
|
| 2023-03-15 15:39:00 |
Proposed issue of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d59e7d097eecd05d42106dc6e0455db5 |
|
| 2023-03-16 10:12:00 |
First Patient Enrolled in USA in Phase II Clinical Trial |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d57c05d91be7227a6041b44977d4862f |
|
| 2023-03-16 17:12:00 |
Application for quotation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/71bcf052d2cbcd6ece8c74e382440344 |
Appendix 2A (Application for Quotation of Securities
|
| 2023-03-16 17:24:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e547a9c84f179b8680e84eb7ba8196e7 |
|
| 2023-03-17 08:15:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4d970d86f67d2fa63fb564fa3c0113ae |
Change in substantial holding
|
| 2023-04-04 10:38:00 |
First Patient Enrolled in UK in Phase II Clinical Trial |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f658bfba0776d39b96a0f3b792185088 |
|
| 2023-04-11 11:02:00 |
Notification of cessation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e60cec8bd6e4c930a3c0957144574209 |
Appendix 3H (Notification of cessation of securities)
|
| 2023-04-26 09:35:00 |
bioMUSE Wearable Sensor Data presented at AAN Annual Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7fb49f67057c0f1641fe6bef07f7f0ba |
|
| 2023-04-27 14:29:00 |
Appendix 4C and Quarterly Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9b0488112799e305a9126fbeb224e557 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
| 2023-05-10 09:37:00 |
First Patient Enrolled in Australia in global Phase 2 Trial |
0 |
https://app.sharelinktechnologies.com/announcement/asx/55c253157816792cf414ab8229c5d5f0 |
|
| 2023-05-30 13:32:00 |
ATH starts 2nd Phase 2 Study in Rare Parkinsonian Disorder |
1 |
https://app.sharelinktechnologies.com/announcement/asx/415fb34cd45202c84a42485a3e3d137a |
|
| 2023-06-21 09:52:00 |
ATH to present at MST Rare Diseases Rich Returns Forum |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01d1ed03b395f4677d67e436d2f1f518 |
Company Administration - Other
|
| 2023-06-22 11:13:00 |
Investor Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/86c352fa092bb50ac62c9b32451c79b0 |
|
| 2023-07-26 09:47:00 |
Ph 2 Data Monitoring Committee Recommends Continuing Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4308ad61b75e4972986223a27c0e1e7b |
|
| 2023-07-31 13:56:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3530ff63f0532cc3cfa3316843862034 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
| 2023-08-15 10:36:00 |
Alterity receives a $4.74 million R&D Tax Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/efc77349e1cf870c318596c3a650ea27 |
|
| 2023-08-22 17:45:00 |
ATH to present New Biomarker data at International Congress |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d822fbf72e14b3ccc2365f56e2e9c244 |
Company Administration - Other
|
| 2023-08-23 14:15:00 |
Alterity Granted New Composition of Matter Patent in Europe |
1 |
https://app.sharelinktechnologies.com/announcement/asx/05384573ab48e736475f4da28850fd75 |
|
| 2023-08-31 09:50:00 |
Alterity Presents New Data on Multiple System Atrophy |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6e3a9691e8f3630df04cc884a670767c |
|
| 2023-08-31 17:11:00 |
Appendix 4E and Annual Report 2023 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/940eb8b5f988ee26e5b0b89f1be42930 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2023-08-31 17:15:00 |
Appendix 4G and Corporate Governance Statement 2023 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/328db5b4eb019ac618527ae892361af3 |
|
| 2023-09-01 11:00:00 |
Alterity Form 20-F and XBRL data filed with SEC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fdbdd55f196819f71d3055140072ca45 |
Company Administration - Other
|
| 2023-09-13 11:34:00 |
Notification of cessation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1e0996de5e1bc82aa28ab7457ee334b9 |
Appendix 3H (Notification of cessation of securities)
|
| 2023-10-03 17:57:00 |
SEC Form F-3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a07be6b643edbae0b36c6c4c0f9b8bb7 |
|
| 2023-10-30 10:14:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cd2a1b3c5048f5b82dfeeeeef041e7a0 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
| 2023-10-31 12:25:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6a7be80fae734c6dffa838ccbdb6cc2b |
Notice of Annual General Meeting
|
| 2023-11-08 09:27:00 |
ATH completes enrolment in ATH434-201 Phase 2 clinical trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4baabf0fd1b9f863b86cf6e694c5536c |
|
| 2023-11-16 09:36:00 |
New Data Demonstrating Novel Mechanisms of ATH434 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0c807ec1814279ee2badb348d0443c18 |
|
| 2023-11-20 09:45:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3ea2eec931a1ad06ea2938895e229163 |
|
| 2023-11-22 09:54:00 |
Alterity Therapeutics Raises $4.8M AUD in Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/47c807c252b66bd60a3cd5e27952c6da |
|
| 2023-11-22 09:55:00 |
Proposed issue of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3aecf298ea880bea42a4b51e1d9a1417 |
|
| 2023-11-22 10:02:00 |
Proposed issue of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aa549bd2cb288e26d55e6debb65a9c21 |
|
| 2023-11-22 10:23:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a9bb703373f129b4c1bed1befec8c9e5 |
|
| 2023-11-22 10:27:00 |
Proposed issue of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5cf3325d7f9cb24b52519a703f9ffc2e |
|
| 2023-11-27 15:47:00 |
ATH presents Novel Biomarker Data for Evaluation of MSA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/15ea2d7694d1b261535c98da03ea6358 |
|
| 2023-11-29 08:16:00 |
Presentation to Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2f5f45638043f5aedfd5532c362f54ec |
|
| 2023-11-29 08:17:00 |
Alterity completes Placement Tranche One raising $1.3M |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f6813c76a13f57a4c50d4f6d62145cee |
|
| 2023-11-29 08:17:00 |
Chairman's Address 2023 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/def0ff62bbf176bc0f784aaab97cff92 |
Chairman's Address to Shareholders
|
| 2023-11-29 08:17:00 |
Application for quotation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/54f4749a71af554862430379633dfc7a |
Appendix 2A (Application for Quotation of Securities
|
| 2023-11-29 08:23:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/802ac9426e5e469e64bf6524d85cfddb |
|
| 2023-11-29 13:15:00 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fc43f6f6d13544ef0bc2434e712a2a2a |
|
| 2023-11-30 09:16:00 |
Notification of cessation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cd8fc4ccd3198cca44080572c909b545 |
Appendix 3H (Notification of cessation of securities)
|
| 2023-11-30 09:25:00 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1ec6a6d23ffa40397d3c810e7439b25c |
Notice of Extraordinary General Meeting
|
| 2023-12-01 08:18:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2cee4bb1c50ee3980e0cbb6c4dac64f3 |
Change in substantial holding
|
| 2023-12-04 09:20:00 |
Positive Efficacy Data for ATH434 in a Primate Model of PD |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c418eab184cf8955ee4695c748b21d79 |
|
| 2023-12-04 16:45:00 |
Webcast to Discuss ATH434 Efficacy Data in Primate Model |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eceaba30e00aef525137cd1e31cfbb9f |
|
| 2023-12-06 18:55:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b660002605f48808cbd0e7d0f914d85a |
Becoming a substantial holder
|
| 2023-12-07 17:58:00 |
Virtual access to Extraordinary General Meeting 29 Dec 2023 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a09d8090f340e240d07ba9ce0c0240f9 |
Notice of Meeting - Other
|
| 2023-12-08 08:16:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fa347c0a233fd09941bcf04d7e31d43f |
Change in substantial holding
|
| 2023-12-08 20:04:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6b64e1a26eef6637578145372e2dfdee |
Change in substantial holding
|
| 2023-12-11 08:14:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9b6e273a68e104fd2aa76e8d9013c531 |
Change in substantial holding
|
| 2023-12-11 17:36:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/19da8a462f32eb8896a63579343e8052 |
Ceasing to be a substantial holder
|
| 2023-12-11 18:16:00 |
Grant of Waiver & Addendum - EGM 29 December 2023 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/04035481a197e22f1a34ef184f0d6759 |
Notice of Meeting - Other
|
| 2023-12-12 08:16:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5a6b63816206a82643ef6f74536bebd5 |
Change in substantial holding
|
| 2023-12-14 08:19:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/365dc5d56d357992ede9d81313e2c108 |
Change in substantial holding
|
| 2023-12-18 09:35:00 |
Update - Proposed issue of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/64b353fc722f193ce40ef60c26ea8c0b |
|
| 2023-12-21 16:13:00 |
Alterity Appoints Phillip Hains as Chief Financial Officer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7e5bb60a4b3fcd979bfcef349f23c467 |
Company Administration - Other
|
| 2023-12-21 17:11:00 |
Notification regarding unquoted securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ed104d7bbcf2abd58cd70fe9bb5c5cee |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2023-12-22 08:23:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/34835c29bf8afd01f9ca0461c5b563a5 |
Change in substantial holding
|
| 2023-12-29 08:32:00 |
Presentation to Extraordinary General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4cc0bacc575dfd0324e56a2f102680a7 |
|
| 2023-12-29 11:40:00 |
Results of Extraordinary General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/832722f0ba2e33d8f38d5821f2d1bd08 |
|
| 2023-12-29 13:16:00 |
Options Prospectus |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b9c353ea06b53f459d213e488d9d9eaf |
|
| 2023-12-29 13:33:00 |
SPP Prospectus |
0 |
https://app.sharelinktechnologies.com/announcement/asx/57aa08f20a1fbb0c9ad5ef2bc1675b30 |
|
| 2023-12-29 13:49:00 |
Shareholders Approve Tranche Two of Placement and SPP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9108ba14dfe9dd3ba9f71a3b6da73b72 |
|
| 2024-01-05 11:31:00 |
Update - Proposed issue of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7081e8a514009880dc278d49d9709f15 |
|
| 2024-01-05 11:42:00 |
Update - Proposed issue of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1bc237e58c2742ac17594ed4ef17e23a |
|
| 2024-01-08 11:08:00 |
Alterity Completes Tranche Two of Placement Raising A$3.5M |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cd2555bfc1f7bc9e7ab82c4ac61dade0 |
|
| 2024-01-08 11:11:00 |
Application for quotation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/75f496f0dd751eb0082cdd8c4035f97d |
Appendix 2A (Application for Quotation of Securities
|
| 2024-01-08 11:17:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d36f51de6ed72782249126d420f1047c |
|
| 2024-01-08 16:41:00 |
Notification regarding unquoted securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/905ed9e6f5d16a500b1c18b86259d38f |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2024-01-10 08:16:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8e1aff8077f3fd66eea4eb753cd05f68 |
Change in substantial holding
|
| 2024-01-10 09:59:00 |
Securities Purchase Plan (SPP) Documents Dispatched |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c483ec78af3936ad975d41e1ac2dcf94 |
|
| 2024-01-10 16:42:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4fd09280210cf8abbbef350af0026a88 |
Becoming a substantial holder
|
| 2024-01-11 14:24:00 |
SPP with Continued Support from Institutional Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5f22a80f511be14327ab3e03eba7b979 |
|
| 2024-01-11 15:08:00 |
Change of Director's Interest Notice PM BM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7d80ea5079dd082f6b4232aa1c2c53da |
Change of Director's Interest Notice
|
| 2024-01-12 08:19:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ae0f27ea334f3d755880f1df4596e6fd |
Change in substantial holding
|
| 2024-01-18 08:18:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0e8a386f5fa323a47ff4f70c39475256 |
Change in substantial holding
|
| 2024-01-18 10:36:00 |
Application for quotation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6cb2577f9041851cfacdeb950c72faa2 |
Appendix 2A (Application for Quotation of Securities
|
| 2024-01-18 11:35:00 |
ATH Long Dated Options Range of Units and Top 20 Holders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ebe203b42204a7f537c0c556cff5b4eb |
Security holder details - Other
|
| 2024-01-22 08:28:00 |
Shareholder Letter Reports Pipeline Advances and Milestones |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6b8d381226ea3ee9aded7170a09c6402 |
|
| 2024-01-31 08:25:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/78c2fdeca7c49fc864a185cf5de6d703 |
Change in substantial holding
|
| 2024-01-31 10:24:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5ece0bbbf1cf5e4579f15ca02c461a1d |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
| 2024-02-01 16:43:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ebb52e9f45395aa0c12e9da820888ad6 |
Ceasing to be a substantial holder
|
| 2024-02-02 09:14:00 |
Alterity Successfully Completes Securities Purchase Plan SPP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/62f6345200b02d8854d328a92ed01316 |
|
| 2024-02-02 09:20:00 |
Application for quotation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3a3f5b8f4f4c4240bb418348fb207fcb |
Appendix 2A (Application for Quotation of Securities
|
| 2024-02-02 09:24:00 |
Notification regarding unquoted securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/65da1c4379fac2df0ba710041f1e22f5 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2024-02-06 08:18:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c1ff92611d6ed4800ac03867277d35fd |
Change in substantial holding
|
| 2024-02-06 14:09:00 |
Phase 2 DMC Recommends Continuing Clinical Trial as Planned |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6fa654f2d122ce35b1ee408e473cb1c5 |
|
| 2024-02-12 08:12:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f10a352bd96edfebe54fe4f9b5702f11 |
Change in substantial holding
|
| 2024-02-16 13:46:00 |
Prospectus Supplement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7b4a5c23ec055d7f52488b3ddc0c74cd |
|
| 2024-02-20 12:21:00 |
Alterity to Present New Data at the AAN 2024 Annual Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d04f3d6a89824f232ff91afbac564ba7 |
Company Administration - Other
|
| 2024-02-22 08:52:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/81a1016eb9c02b72e4e941c36c53cc65 |
|
| 2024-02-23 10:18:00 |
Proposed issue of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/67b4c2d2d28dc699e6a9e26abdbe73b3 |
|
| 2024-02-23 10:18:00 |
Alterity Therapeutics Raises $3.25 M AUD in Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5cbaa7602d55f929801ba74c29e5e2fa |
|
| 2024-02-23 10:18:00 |
Proposed issue of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ff075ac0585dd6277327c5fa149e27eb |
|
| 2024-02-28 16:07:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1b0d87749a77f2a03dbe7bba46b48e77 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2024-02-29 08:09:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/16429272007df30f304e82260a86892c |
Change in substantial holding
|
| 2024-03-04 10:29:00 |
Application for quotation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d2b417a8f60bfaf1f6951553fbc52f1a |
Appendix 2A (Application for Quotation of Securities
|
| 2024-03-04 10:34:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/78d2aa60ff07089cbcc104d90d361434 |
|
| 2024-03-06 08:18:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/23db774ece7d9c27876e41dfad674974 |
Change in substantial holding
|
| 2024-03-07 08:15:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a9f65412cdbc3ff1ed9aaeaf8ad49093 |
Becoming a substantial holder
|
| 2024-03-14 09:08:00 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1876ecb30a63610652af0c213d8eb9fe |
Notice of Extraordinary General Meeting
|
| 2024-03-25 08:21:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c1202bd22811533e49d5f7cd83a1cc05 |
Change in substantial holding
|
| 2024-03-26 13:15:00 |
Alterity Receives a $3.9 million R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6ff85aaa70d6770b3e26e19b2287b70e |
|
| 2024-04-10 08:35:00 |
Alterity to Present New ATH434 Data at Orphan Drug Congress |
0 |
https://app.sharelinktechnologies.com/announcement/asx/63210d524f0b7e49d6682fe8b1387c95 |
Company Administration - Other
|
| 2024-04-12 10:47:00 |
Results of Extraordinary General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aa7f06ec917ba0873f87d9fbc06003db |
|
| 2024-04-12 11:30:00 |
Options Prospectus |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b7e7d9a78d5240a3097df143631a4220 |
|
| 2024-04-15 10:40:00 |
Application for quotation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f11fd9c2e612b4e3bd8a7c1d4eaf2a0d |
Appendix 2A (Application for Quotation of Securities
|
| 2024-04-17 08:48:00 |
Alterity Parkinson's and MSA Data Featured at AAN Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2e471a8223469d523ac688d86dd3b605 |
|
| 2024-04-18 08:24:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d9adffd9bb106afb185dc8780f47d4f9 |
Change in substantial holding
|
| 2024-04-29 08:41:00 |
Alterity Presents New Data on ATH434 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/94a74192c6e2c779a5cf34c53afe9103 |
|
| 2024-04-29 09:01:00 |
Application for quotation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4c91a046453949e39f14883d71e7ab64 |
Appendix 2A (Application for Quotation of Securities
|
| 2024-04-30 09:06:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/56962653cb63b79a7d87bd05ccc1556e |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
| 2024-05-03 08:23:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eb5e042f8874a53ad0150369db2257db |
Change in substantial holding
|
| 2024-05-08 08:20:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3876016313aa265702f96df1687552eb |
Ceasing to be a substantial holder
|
| 2024-05-08 08:27:00 |
Phase 2 DMC Recommends Continuing Clinical Trial as Planned |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5efd628bc4ec9a69eaa069017450862f |
|
| 2024-05-21 15:19:00 |
Notification of cessation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9d7a70e6b24c978298f5afd3653c2853 |
Appendix 3H (Notification of cessation of securities)
|
| 2024-05-30 08:39:00 |
Webcast Today - New Data from bioMUSE Natural History Study |
0 |
https://app.sharelinktechnologies.com/announcement/asx/106070fd61c396f191a8bf902bce7877 |
Company Administration - Other
|
| 2024-06-13 08:42:00 |
Alterity to Present at Hidden Gems in Life Sciences Webinar |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b8447e85db063dcb348f4461db20e037 |
|
| 2024-06-28 16:58:00 |
Notification regarding unquoted securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a8b1395931a1774358b7e4055f650858 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2024-07-15 09:25:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bf83e3caf8c77901ff2e0fc5a753f5f6 |
|
| 2024-07-17 10:20:00 |
Positive Interim Data from ATH434-202 Phase 2 Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0470084fed5357c159c7a61787dd28a5 |
|
| 2024-07-18 12:16:00 |
Proposed issue of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ae0249051d8993d18990424d3ac5df8f |
|
| 2024-07-19 12:17:00 |
Application for quotation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ebe365a39a82a44540aeedf87f7d0705 |
Appendix 2A (Application for Quotation of Securities
|
| 2024-07-19 12:19:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/383af9251e21e9c930733a7ceda4adf6 |
|
| 2024-07-24 11:15:00 |
Alterity Therapeutics to Present at MST Financial Webinar |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5ccbf8bdc75928179ae0e8a80a5c5d16 |
Company Administration - Other
|
| 2024-07-31 08:12:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/455858defdca3bc4386c31e105788c4e |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
| 2024-08-01 08:35:00 |
Notification of cessation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/544a2888b2e4d91ed03f56ca21f29d15 |
Appendix 3H (Notification of cessation of securities)
|
| 2024-08-29 13:23:00 |
Appendix 4E Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e6dd27f01764523edac3cfdd92bf3b3a |
|
| 2024-09-02 11:41:00 |
Notification of cessation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/92af2f5f048983a0de67981db565e68f |
Appendix 3H (Notification of cessation of securities)
|
| 2024-09-20 08:17:00 |
Change of Director's Interest Notice - BM / PM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ccf3e14c9007fb42dad9d44b5891a272 |
Change of Director's Interest Notice
|
| 2024-09-23 09:33:00 |
Alterity to Deliver Multiple Presentations at MDS Congress |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9c2819685756b46366319ec28291a782 |
Company Administration - Other
|
| 2024-09-26 13:09:00 |
Annual Report 2024 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/247d89763bec4e6bc1691dff7ba7ffee |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2024-09-26 13:15:00 |
Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/805ee0f1998215a1e44d819b8e479fc7 |
|
| 2024-09-26 13:20:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/71f02ddf81071fc81d27bcf376a7a671 |
|
| 2024-09-30 09:00:00 |
ATH Appoints Abby Macnish Niven as Chief Financial Officer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ebb275d929edb578e566d59f2e6a8db1 |
Company Administration - Other
|
| 2024-09-30 13:32:00 |
Alterity Therapeutics Filed Form 20-F and XBRL data with SEC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/db3f3f775fbe76bc1b28748b435100e1 |
Company Administration - Other
|
| 2024-10-02 11:43:00 |
Alterity Data Presentations at MDS Congress Raises Profile |
0 |
https://app.sharelinktechnologies.com/announcement/asx/834bb87812aade814bb4c75b50919a4c |
Company Administration - Other
|
| 2024-10-04 13:05:00 |
Change of Share Registry |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ca437dbddbe7696d6dd68fb361372f9f |
Details of Share Registry address
|
| 2024-10-11 09:36:00 |
Alterity Presents Data Describing Neuroprotection of ATH434 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6d682e37296279aeb962006b2fc20b3c |
|
| 2024-10-14 11:07:00 |
ATH to Participate in 2024 Maxim Healthcare Virtual Summit |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1d1e34c26cdbd1fbbe0f5729f0f183a4 |
Company Administration - Other
|
| 2024-10-23 09:56:00 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7cdc0075ea809585dca4cb33e0963c5c |
Notice of Annual General Meeting
|
| 2024-10-31 12:11:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4f323929b3297d3671e4bcf686dd7dbe |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
| 2024-11-06 09:17:00 |
Alterity Announces Publication On ATH434 Mechanism of Action |
0 |
https://app.sharelinktechnologies.com/announcement/asx/692256a4e04979c04b1923a845445a81 |
Company Administration - Other
|
| 2024-11-12 10:10:00 |
ATH Presentation Tracking MSA Progression at Intl Symposium |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7eaa19da7f6a50f1245141f2a34032bb |
|
| 2024-11-19 14:34:00 |
Change of Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/58a28605387a172c6bb764b4bf9e2da2 |
Company Secretary Appointment/Resignation
|
| 2024-11-22 08:51:00 |
Chairman's Address 2024 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b25ee0e9669d8770d456c2e216ce1d3b |
Chairman's Address to Shareholders
|
| 2024-11-22 08:57:00 |
Presentation to Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2f77e7f8a69a0157785738a9c06ecb19 |
Chairman's Address to Shareholders
|
| 2024-11-22 11:33:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/92a02f35e3fa7958ec71845e5a61fadf |
|
| 2024-12-04 09:38:00 |
Alterity Announces Completion of Phase 2 Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a3899c0e716e0b909262cc3130b1d27f |
|
| 2024-12-31 08:33:00 |
Notification regarding unquoted securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/08f9c6d5f83bf6e0a080e7ab346757e0 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2025-01-06 16:17:00 |
Change of Director's Interest Notice x 4 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fbf9bb7324322ac0fa31ba64eaadd32d |
Change of Director's Interest Notice
|
| 2025-01-17 14:43:00 |
ATH shareholder newsletter January 2025 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a64b6d3d5537670b7f204d7e0155ebb7 |
|
| 2025-01-22 16:50:00 |
Application for quotation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ac36574a4ff05c00f38c741ebc183705 |
Appendix 2A (Application for Quotation of Securities
|
| 2025-01-24 14:52:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a17a5c66dd04817713e6e0cda9b6ced8 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
| 2025-01-28 08:43:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a7a2bd6808bd0d2950bd4fbda1194e20 |
|
| 2025-01-30 09:20:00 |
Positive ATH434 Phase 2 Results Led By Clinical Efficacy |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9330cb721d4d163946487909b4df5b4f |
|
| 2025-01-30 15:34:00 |
ATH434-201 Phase 2 Topline Results Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6434973a6d6c166d365417b950070513 |
|
| 2025-01-30 17:01:00 |
Application for quotation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d6235784bc633f9ed214617684950380 |
Appendix 2A (Application for Quotation of Securities
|
| 2025-02-03 09:54:00 |
Alterity Raises Funds for ATH434 BD and Clinical Activities |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9389cc2610a7d8083fdd39d3183238ec |
|
| 2025-02-03 09:58:00 |
Proposed issue of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d45e8bfc0663267c8afff6ab40bf6cff |
|
| 2025-02-04 11:57:00 |
Application for quotation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/83d457bc1165c408ce0c8bc4e82dc8b4 |
Appendix 2A (Application for Quotation of Securities
|
| 2025-02-04 12:00:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3c46c24812c94d58c4caca7104830272 |
|
| 2025-02-05 08:23:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9fe95cace4cf584b2e2018c7f3327630 |
Change in substantial holding
|
| 2025-02-05 14:14:00 |
Disclosure under Takeovers Panel GN 20 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c648afb114cc42d8770b1a4e0a6c9ac3 |
Security holder details - Other
|
| 2025-02-06 08:20:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9145ed5809a5bee8cd681c3520903a2c |
Becoming a substantial holder
|
| 2025-02-06 08:55:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ed309111ab236f6b80cb16ed327bccfc |
|
| 2025-02-07 08:21:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6d5a927e853c5f069fbe79be06242c8a |
Ceasing to be a substantial holder
|
| 2025-02-10 10:23:00 |
Alterity raises A$40m to Advance ATH434 Development in MSA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ac6c0f8df55a2ee02ec45500f7320b7b |
|
| 2025-02-10 10:25:00 |
Proposed issue of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ae5a45c6569897ad71e844453cd3b2a8 |
|
| 2025-02-17 09:07:00 |
Application for quotation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b3f57fc8ba21f18ac139ef46d5d9c0e3 |
Appendix 2A (Application for Quotation of Securities
|
| 2025-02-17 09:15:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/524f938712a6ee42bba479a0c35a64da |
|
| 2025-02-19 08:19:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/90d6c50181668c1b70ac0257165ddb79 |
Change in substantial holding
|
| 2025-02-24 16:07:00 |
Proposed issue of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/abfb0757cb3bc46e29dbf12b0b613f89 |
|
| 2025-02-28 12:09:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6b34dd26278311b731d92b57d1fcd41f |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2025-02-28 12:30:00 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/786790b2c52e5b04b80c6d18bc2009d4 |
Notice of Extraordinary General Meeting
|
| 2025-03-13 19:55:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bc488ea71494e5617927e9e25c0e9e1f |
Becoming a substantial holder
|
| 2025-03-14 14:06:00 |
Application for quotation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3695666151e90c955c5eff576d00f59a |
Appendix 2A (Application for Quotation of Securities
|
| 2025-03-24 19:20:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9ebec3083083195b84496774e5cad7e8 |
Ceasing to be a substantial holder
|
| 2025-03-27 10:41:00 |
Alterity Completes Last Patient Visit in Open-Label Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/26a3623738a8dfbca7d7475e0c572009 |
|
| 2025-03-31 12:13:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/844d887b3e47918dcde784f8fabd4036 |
|
| 2025-04-03 09:51:00 |
Alterity to Deliver Oral Presentation of ATH434 Trial at AAN |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8432d4e685af41047743141761e4421d |
Company Administration - Other
|
| 2025-04-07 09:41:00 |
Application for quotation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2d882b572ac2acd22805318ee1395eda |
Appendix 2A (Application for Quotation of Securities
|
| 2025-04-07 09:43:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/90ecdf654bffb5cd8b8ce8cf4a355928 |
|
| 2025-04-07 09:49:00 |
Completion of Placement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5a39bf85fc67c9f5075d341427bbbab2 |
|
| 2025-04-08 08:21:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8bc224dfc3163653f74f195a42b7466a |
Change in substantial holding
|
| 2025-04-08 17:33:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fb08af8b7fdddcea666556e2208fa07f |
Becoming a substantial holder
|
| 2025-04-09 16:26:00 |
Change of Director's Interest Notice x 3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/613f27b77621bd25b7e44e02a938661f |
Change of Director's Interest Notice
|
| 2025-04-10 10:11:00 |
Alterity Presents Encouraging New Phase 2 Data in MSA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cd91399c0778a29a24e57ed3d61cdd30 |
|
| 2025-04-10 13:59:00 |
Alterity Phase 2 Presentation at AAN 2025 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1c750c506ac8370fe7bc0079a61f324f |
|
| 2025-04-17 13:56:00 |
Options Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e8218236c139cb85f61731cb7bce2506 |
|
| 2025-04-22 08:59:00 |
Updated Corporate Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e0ee23c02d34e28b1574aab2fec8b59c |
|
| 2025-04-22 09:55:00 |
Application for quotation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/71f3f9b4b74a39e1b2357574f56590ef |
Appendix 2A (Application for Quotation of Securities
|
| 2025-04-22 10:31:00 |
New Options - Top 20 Holders and Range of Units |
0 |
https://app.sharelinktechnologies.com/announcement/asx/51e6c0aabf85b0e38c1cb25f5686dbd2 |
Security holder details - Other
|
| 2025-04-28 10:18:00 |
Alterity Phase 2 Presentation at MSA Symposium 2025 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/60b2035f4a911684288765911cc24c3c |
|
| 2025-04-29 13:08:00 |
Change of Director's Interest Notice x 3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/89216d6881d4f905abe6536220fbde37 |
Change of Director's Interest Notice
|
| 2025-04-30 09:30:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f00830bed431216b715c6dabff9c6627 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
| 2025-05-05 08:53:00 |
Alterity Granted U.S. FDA Fast Track Designation for ATH434 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8490d282513622d06f970c1e3b3e5387 |
|
| 2025-05-07 13:00:00 |
Alterity Phase 2 Data to be Featured at MSA Congress |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6ca18387c9140b44df519260e650da5f |
Company Administration - Other
|
| 2025-05-12 08:16:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ea633074cad6af22498fa3c08802af50 |
Change in substantial holding
|
| 2025-05-12 09:54:00 |
Alterity Prominently Featured at International MSA Congress |
0 |
https://app.sharelinktechnologies.com/announcement/asx/be838399d43ae6577680d696a9e8bd63 |
|
| 2025-05-23 08:20:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2cb55aac2d10daf6f8bc2df1f2cc4f85 |
Change in substantial holding
|
| 2025-06-23 11:38:00 |
Alterity CEO to Provide Corporate Update on ATH434 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f5ea062b9bbe12de778e854fa724ed4d |
|
| 2025-06-30 12:01:00 |
Notification of cessation of securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c3291b54c08b92dbe6ad93708c7c6f32 |
Appendix 3H (Notification of cessation of securities)
|
| 2025-07-03 10:13:00 |
Notification regarding unquoted securities - ATH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ebe34dc08dd9dcd1d028edac21efec6f |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|